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ABSTRACT 
 There is an increasing prevalence of chronic disease and obesity in the United States.  
Bioactive compounds which have been shown to prevent and alleviate disease states can aid in 
decreasing this prevalence.  The addition of these compounds to food products would help to 
deliver these health benefits to consumers.   
 Challenges such as instability in environmental conditions and the digestive system, as 
well as negative sensory properties of the bioactive compounds limits the addition of these 
compounds to food products.  Encapsulation is a processing technique that can help to 
overcome these challenges and increase the range of food products into which the compounds 
can be incorporated within.  The long term goal of this research is to enhance stability and ease 
of consumption of bioactive compounds by way of utilizing microencapsulation, which will 
increase the consumption of these healthful ingredients.     
This research utilized resveratrol, a polyphenol found in red grapes and wine, as a 
model compound which encapsulation was applied in order to overcome the light instability and 
bitterness of the compound.  Resveratrol was encapsulated within a protein matrix through 
spray drying.  Encapsulated resveratrol within a sodium caseinate matrix had a higher UVA light 
and digestive stability (0.63 trans:cis resveratrol ratio and 84%) than unencapsulated resveratrol 
(0.49 trans:cis resveratrol ratio and 47%).  In addition, the encapsulation of resveratrol 
decreased the detection of the compound in comparison to unencapsulated resveratrol.  The 
resveratrol microcapsules were added to snack bars and gummies in order to show application 
of the stabilized resveratrol.  A group of consumers was identified who’s overall liking for the 
food products were maintained with the addition of the encapsulated resveratrol.   
The encapsulation-system approach developed in this research can be extended to 
other bioactive compounds in order to increase stability and minimize negative sensory 
properties of the target compounds, while delivering the health benefits of the compounds.  This 
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research serves as a basis upon which additional research can tailor the encapsulation-system 
approach for the specific properties of the compound. 
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CHAPTER 1: INTRODUCTION 
1.1 Motivation 
 In the United States, more than 1/3 of adults are obese which poses concern as many 
chronic diseases, such as heart disease, stroke, diabetes, cancer, liver problems, and 
respiratory problems, are related with obesity [1, 2]. The overall medical cost in the United 
States related to obesity in 2008 was $147 billion dollars [2]. 
 Healthy eating habits and regular exercise can help to combat obesity and rising 
prevalence of chronic disease in the United States.  With this being said, it is often difficult for 
people to change their lifestyles.  Therefore, the addition of healthful compounds to food 
products can provide the health benefits in easy-to-consume foods and provide a convenient 
means for the compounds to be delivered to consumers.  
 Resveratrol was a compound of interest due to its association with beneficial effects on 
heart disease, cancer, diabetes, and neurological function [3-6].  Some of the challenges with 
the incorporation of resveratrol into food products are instability in light, bitterness, and low 
bioaccessibility through the human digestive system [7-9].  The long term goal of this research 
is to enhance stability and ease of consumption of bioactive compounds by way of utilizing 
microencapsulation, which will increase the consumption of these healthful ingredients.    The 
central hypothesis is microencapsulation of resveratrol within a protein matrix will affect 
stability and sensory properties of the compound.    
1.2 Project Objectives 
Objective 1 
 The first objective of this research was to stabilize trans-resveratrol in the presence of 
light and through the human digestive system.  A common processing technique and cost-
effective encapsulation material would be desirable in order to make scale-up and application in 
the food industry feasible.  The working hypothesis for this objective was the use of 
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microencapsulation will increase the stability of resveratrol as evaluated through UV light and in-
vitro digestion testing.   
Objective 2 
 The second objective of this research was to evaluate the sensory properties of the 
stabilized resveratrol.  Taste is one of the most important considerations when consumers are 
purchasing a product [10].  Even if a product contains a healthful compound, it needs to have a 
high acceptability in order for consumers to repeatedly purchase the product.  The working 
hypothesis for Objective 2 was the incorporation of resveratrol into a microcapsule will increase 
the taste detection threshold of the compound, and further, not compromise consumer 
acceptance of food products with encapsulated resveratrol.   
 1.3 Outline of Thesis 
Chapter 2 is a literature review that provides an overview of resveratrol, associated 
health benefits, regulations, challenges with incorporation into food products, binding between 
resveratrol and protein, resveratrol recovery, bioaccessibility, processing methods to stabilize 
resveratrol, and sensory properties of the compound.  
Chapter 3 evaluates the stability of resveratrol in the four resveratrol microcapsule 
formulations under UVA light and in-vitro digestion testing.  Two proteins (whey protein 
concentrate and sodium caseinate) and the effect of fat within the encapsulation matrix were 
compared as wall materials in the microcapsules.  In addition, the quantification of binding 
between resveratrol and protein was explored.  Resveratrol recovery from the microcapsules 
was limited, thereby, prompting interest in the investigation of the interaction between 
resveratrol and protein which may limit the ability for resveratrol to be extracted from the 
microcapsules.  It was thought that binding between resveratrol and protein plays a significant 
role in stability of the compound. 
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Chapter 4 investigates the effect of plasticizers in the resveratrol microcapsule 
formulation in terms of morphology of the microcapsules and UV stability of resveratrol.  The 
effect of plasticizer concentration and the use of protein denaturation on resveratrol stability 
within the microcapsule was also studied in terms of UV stability. 
Chapter 5 compares the taste detection threshold of resveratrol and resveratrol 
encapsulated within a protein matrix.  The R-index measure by the signal detection rating 
method in comparison to the noise and signal sample was utilized in this study.  Resveratrol 
was tested in 6-concentration levels that differed in 3-fold increments, ranging from 2.2-540 
mg/L for unencapsulated resveratrol and between 4.4-1080 mg/L for encapsulated resveratrol.   
Chapter 6 assesses consumer acceptance of bars and gummies with added resveratrol 
microcapsules and unencapsulated resveratrol.  Resveratrol was added to the food products at 
concentrations of 10 and 40 mg/serving.  These levels of resveratrol have been shown to 
provide health benefits in humans [4, 11].  Panelists rated the overall liking of each product 
along with indicating which attributes they liked and disliked about the products.  This testing 
gives indication of consumer perception of products with added resveratrol.   
Chapter 7 concludes this dissertation with a summary of research findings, implications 
to the food industry, and explanation of future research.   
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CHAPTER 2: LITERATURE REVIEW 
2.1 Introduction 
Resveratrol (3,4’,5-trihydroxystilbene) found in red grapes and peanuts has been shown 
to have numerous health benefits associated with heart disease, cancer, diabetes, neurological 
function and other biological functions [1-6].  It has also been shown to have anti-microbial and 
anti-oxidant properties [7, 8].  The trans-isomer of resveratrol is the form which has been 
associated with health benefits, but instability in light, insolubility in aqueous solutions, low 
bioaccessibility and bitterness limit the range of products into which the compound can be 
incorporated [9-12].   
Various processing methods are being used to overcome the challenges of resveratrol 
incorporation into foods.  Processing methods can aid in the innovation of enhancing stability 
and decreasing negative sensory properties of resveratrol.  Innovative processing methods can 
aid in the incorporation of resveratrol into foods with the long term goal of providing the health 
benefits of the compound to consumers.  In terms of stability, prior research was mainly focused 
on the encapsulation of resveratrol in order to limit isomerization of the compound.  The 
encapsulation techniques which have been explored in prior research are cyclodextrin 
complexes, porous microspheres, cross-linked chitosan, pectinate beads, lipid nanoparticles 
and carriers, double emulsions, nanoencapsulation, and niosomes [13-19].  In addition, 
processing methods to increase the solubility of resveratrol through addition of stevioside and 
application to food systems such as hazelnut paste and edible films have been researched [20-
22].  There are limited published studies available on the sensory properties of resveratrol.   
2.2 Health Benefits 
 Extensive research supports resveratrol is associated with health benefits related to 
heart disease, cancer, diabetes, neurological function, and other biological activities [1-6].  
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Table 2.1 summarizes the extensive body of literature on various health benefits according to 
the type of animal model used in the research.   
2.2.1 Cardiovascular Disease 
Research findings support that resveratrol lowered platelet aggregation in platelet-rich 
plasma and isolated human platelets [23, 24].  It was also able to lower total cholesterol and 
low-density lipoprotein (LDL) levels in hypercholesterolaemic rats [1].  In addition, resveratrol 
was able to improve vascular function by decreasing total plasma cholesterol and cholesterol in 
lipoprotein fractions in mice [25].  An increased recovery at reperfusion and significant 
vasodilation which indicates cardioprotection was also found in rats [26].  The effects of 
resveratrol on heart disease were also investigated in guinea pigs and found to increase cardiac 
DT-diaphorase and catalase activity.  It also resulted in relaxation of arteries which supported 
the cardioprotective effects of the compound [27, 28].   In rabbits, resveratrol intake helped to 
suppress atherosclerosis and ADP-induced platelet aggregation, indicating prevention of 
coronary heart disease [24, 29].  Furthermore, a dose dependent inhibition of platelet 
aggregation and increased cerebral blood flow were reported when resveratrol was 
administered to humans, which indicated a decreased risk of cardiovascular disease [3, 24, 30]. 
2.2.2 Cancer  
A second health benefit of resveratrol is its ability to prevent cancer and slow tumor 
growth.  It is thought that resveratrol can inhibit carcinogenesis at multiple stages.  Resveratrol 
has been tested against ovarian carcinoma cell lines, and it was found to inhibit the proliferation 
and survival of these cells; thereby causing autophagocytosis that helps to maintain 
homeostasis in cells [31].  In other cell lines, resveratrol helped to decrease basal production of 
PGE2, inhibit PMA-mediated activation of protein kinase C and COX-2, and decrease ornithine 
decarboxylase activity [32-34].  These changes in biomarkers were indications of inhibiting 
cancer proliferation.  The administration of resveratrol to rat and mice models helped to prevent 
initiation and progression of tumor growth, even decreasing tumor size and increasing survival 
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of the animal [1, 35-46].  Healthy adults were given 0.5, 1, 2.5 or 5 g of resveratrol/day and a 
decrease in IGF-1 and IGFBP-3 was observed, which indicated chemoprotection [47]. 
2.2.3 Diabetes Mellitus 
Thirdly, resveratrol has been associated with the prevention and treatment of diabetes 
mellitus.  Resveratrol has been found to have an anti-hyperglycemic effect and also reduced 
glycosylated hemoglobin that further confirmed a reduction in blood sugar [48-51].  Resveratrol 
facilitated intracellular glucose transport even in the absence of insulin [52].  Furthermore, 
insulin sensitivity was increased in healthy rats and also in insulin-resistant mice on a high-fat 
diet after the consumption of resveratrol [51, 53].  In diabetic males, resveratrol has been shown 
to decrease blood glucose and insulin resistance, showing positive effects on diabetes [4, 5]. 
2.2.4 Neurological Function 
The fourth health benefit of resveratrol is an increase in neurological function.  It has 
been found that resveratrol helped to reduce neuronal cell death and neurotoxicity in an 
Alzheimer’s mouse model [2].  Another study found resveratrol was able to reduce amyloid 
plaques in mice which is thought to be associated with decreased glutathione and increased 
cysteine [54].  Furthermore, other biomarkers such as NF-kappaB p65 expression, and 
decreased malondialdehyde levels are thought to be related to improved neurological function 
[55-57].  Research have shown that resveratrol intake stimulated Sir1, that inhibited nuclear 
factor κB signaling which helped to prevent β-amyloid toxicity and showed a therapeutic effect 
against Alzheimer disease [58].   
2.2.5 Lifespan 
Not only has resveratrol been associated with the prevention of disease states but also 
an increase in lifespan.  Sirtuins are a group of genes associated with the aging pathway; 
therefore, the up-regulation of these genes is correlated with increased lifespan.  In yeast, 
resveratrol has been shown to activate Sir2 and increase lifespan by 70% [59].   Another study 
has paralleled studies in yeast finding that resveratrol was able to increase lifespan in flies, fish, 
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worms, and mice [60-63].  Lagouge and others (2006) found that resveratrol intake prevented 
diet-induced obesity, increased aerobic capacity and inhibited muscle fatigue in mice [64].  
2.2.6 Obesity 
 Resveratrol has also been shown to have positive effects on obesity.  A resveratrol 
supplementation of 0.4% to mice on a high-fat diet was shown to decrease body weight gain, 
visceral fat, and plasma biomarkers related to adipogenesis and inflammation [65].  In non-
human primates, it was found that 200 mg resveratrol/kg body weight/day reduced energy 
intake by 13% and increased resting metabolic rate by 29% [66].  It is hypothesized that 
resveratrol can increase satiety thereby decreasing energy intake and increasing energy 
expenditure.   
2.3 Anti-microbial and Anti-oxidant Functions 
Additional functional properties of resveratrol include its ability to serve as anti-microbial 
and anti-oxidant agents.  At concentrations of 11 and 22 mg/L, resveratrol was shown to inhibit 
the growth of Saccharomyces cerevisiae, Penicillium expansum, and Aspergillus niger [7].  The 
effectiveness of resveratrol against HIV has also been shown [67, 68].  The ability of resveratrol 
to increase oxidative stress tolerance was studied in yeast.  The yeasts were exposed to 
oxidative agents such as CCl4 and H2O2.  In the presence of resveratrol, there was a significant 
increase in survival rate and reduction in lipid peroxidation [8].   
2.4 Resveratrol Sources 
 Resveratrol is naturally found in low concentrations in some fruits, wine, and nuts.  The 
concentrations of resveratrol in red grapes, red wine, white wine, peanuts, and blueberries are 
0.050 mg/100 g, 0.002-0.653 mg/L, trace-0.100 mg/L, 0.002-.0179 mg/100 g, and trace-0.003 
mg/100 g, respectively [69-72].  The higher resveratrol content in peanuts than red grapes may 
be due to the high water content in grapes in comparison to peanuts.  Therefore, it appears 
there is a lower concentration of resveratrol in red grapes.   
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2.4.1 Resveratrol as a Defense Mechanism in Plants 
 In plants, resveratrol may be produced as a defense mechanism to fungal invasion and 
other physical damage [71].  This defense mechanism has been specifically observed in 
peanuts that may provide an explanation for the wide range of resveratrol concentration found in 
this food source.  When peanut seedling leaves were exposed to UVC irradiation, it was found 
that endogenous resveratrol increased significantly within 24 hours of exposure [73].  The 
effects of UVC irradiation was also explored in grape leaves [74].  Endogenous resveratrol was 
shown to increase 180-196 fold in comparison to the control (not exposed to UVC light) at 16 hr 
and 24 hr.  Stilbene synthase, which is an important enzyme in the resveratrol biosynthesis, was 
also increased in the grape leaves after UVC exposure.   Aluminum chloride has also been used 
to enhance accumulation of resveratrol in grape vine leaves [75].  All concentrations of 
aluminum chloride which were tested, 7-90 mM of aluminum chloride, were shown to induce 
resveratrol production.  In addition, resveratrol has been shown to be produced as a defense 
response to Botrytis in grapevines.  The level of resveratrol production was correlated to the 
level of pathogen infection [76].  Resveratrol has also been shown to be produced when 
grapvines were infected with mildew disease [77].   
2.4.2 Transgenic Fruit with High Resveratrol Content 
 The concentration of resveratrol shown to have biological effects in humans is higher 
than that naturally found in plants.  Therefore, transgenic produce have been developed in order 
to increase resveratrol concentration in natural sources of resveratrol.  A stilbene synthase 
gene, associated with resveratrol production in fruits and vegetables, has been overexpressed 
in order to increase resveratrol content in lettuce [78].  Resveratrol content in the lettuce 
reached 56.40 ± 5.52 ug/g.  Stilbene synthase gene has also been used to increase resveratrol 
glucoside, a resveratrol derivative in apples [79].   
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2.5 Regulations 
Currently, resveratrol is not regulated as a drug in the United States and instead is 
considered a dietary supplement [80].  The Dietary Supplement Health and Education Act of 
1994 made it the responsibility of manufacturers to determine the safety of compounds such as 
resveratrol.  Under this law, the manufacturers can provide basic information about the 
mechanism by which the supplement affects “the structure or function of humans” but claims 
about the treatment or prevention of diseases cannot be made [81, 82].  Little is known about 
the amount of resveratrol intake that is considered safe.   
The safety of resveratrol consumption is a viable concern when considering the 
incorporation of the compound into food products.  No adverse effects were seen in rats when 
fed 50-700 mg resveratrol/kg bw/day for 28-90 days [83].  Other research found a decrease in 
white blood cells when rats were fed 450 mg resveratrol/kg bw/day for 56 days [53].  No serious 
effects were seen when healthy adults were given a 0.5-5 g single dose, but minor effects such 
as increased bilirubin and alanine aminotransferase were seen at a 1 g dosage [84].  Headache 
and dizziness were also seen in healthy adults when given a total of 150-900 mg resveratrol/day 
in small dosages every 4 hours [85].  The effects of resveratrol in rats and humans have been 
shown to not be serious, and the dosages that have been used in safety testing are well above 
those which have been shown to have biological effects.   
2.6 Challenges 
The incorporation of resveratrol into food products would help to deliver the health 
benefits of the compound to consumers, but resveratrol is unstable in certain environmental 
conditions such as light, pH and heat.  The activation energy to isomerize trans-resveratrol to 
cis-resveratrol has been found to be ~3.7 kcal/M [72].  This activation energy is relatively low as 
the activation energy to go from H2O2  H2O + O2 was ~10 kcal/M [86].  The biggest challenge 
behind the addition of resveratrol to food products is instability of resveratrol in the presence of 
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light [9, 87].  After one hour of exposure to light, 80-90% of trans-resveratrol (bioactive) was 
converted to cis-resveratrol (bio-inactive) [87].  Another study found that about 90% of trans-
resveratrol was converted to cis-resveratrol after UV exposure for 120 min at 366 nm [9].  
Trans-resveratrol was most stable between pH 5-8 as the isomerization was slowest in this pH 
range [88].  Heat is another factor that can lead to instability of trans-resveratrol.  Exposure to 
190°C for 18 min has been shown to degrade 17-46% of resveratrol in blueberries and 
biliberries [70]. 
Another challenge with resveratrol incorporation into food products is its limited solubility 
in both aqueous and lipid solutions.  The reported amount of soluble resveratrol was 0.03 
mg/mL in water [10] and 0.18 mg/mL in coconut oil [89]. It is soluble in ethanol at 50 mg/mL and 
also in dimethyl sulfoxide at 16 mg/mL [10].  Additionally, relative humidity has not been found 
to affect isomerization of trans-resveratrol significantly at 25°C when relative humidity was 
increased from 75% to 90% [90]. 
2.7 Bioavailability and Bioaccessibility 
An important consideration when processing resveratrol for incorporation into food 
products is the bioavailability and digestibility of the resveratrol.  When resveratrol was 
administered orally through a drink, serum resveratrol levels peaked at about 30 minutes post-
consumption and less than 2% of resveratrol was found in the trans-isomer [91].  Other 
research showed that resveratrol glucuronides and sulfates were mainly found in the plasma 
and were detected for a prolonged amount of time.  Walle and others (2004) found that in 
addition to glucuronic acid and sulfate metabolites, the hydrogenation of aliphatic double bonds 
also occured.  The majority of the metabolites were found in the urine [92].  These findings 
suggested that the resveratrol was partly metabolized in the small intestine and then distributed 
to various parts of the body in conjugated form [11].  This theory was supported by another 
research study as 50% of trans-resveratrol and derived metabolites administered to pigs was 
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found in the jejunum and ileum of the small intestine [93].  Resveratrol metabolites have been 
found to accumulate in the liver probably due to partial metabolism of the compound in the liver 
and also the transport of metabolites from the intestine.  In the kidneys, resveratrol levels 
gradually decreased with time that suggested that renal excretion is one of the predominant 
means of elimination [11].  Therefore, these findings support that resveratrol readily breaks 
down in the body resulting in low bioaccessibility and bioavailability. 
2.8 Increasing Stabilization and Bioaccessibility 
 Research has explored various ways to overcome the challenges of resveratrol related 
to instability and low bioaccessibility.  The main method of stabilizing resveratrol is 
encapsulation that helps to prevent isomerization and maintain the bioactivity.   
2.8.1 Cyclodextrin Complexes 
 Cyclodextrin complexes are the most common form of resveratrol stabilization.  The 
number of glucose residues connected by α(14) glycosidic bonds can range from six to eight.  
Cyclodextrins can form inclusion complexes with a wide range of compounds as they have a 
hydrophobic inner cavity and hydrophilic capsule walls.  In this way, resveratrol can form an 
inclusion complex with the hydrophobic cavity thereby protecting resveratrol [13].  In all the 
studies involving encapsulation of resveratrol by cyclodextrin complexes, antioxidant testing was 
the primary means to evaluate the microcapsules.  β- and maltosyl-β-cyclodextrins have been 
used to form complexes with resveratrol and testing supported that biological activities were 
maintained.  Oxidation of resveratrol by lipoxygenase was tested for both cyclodextrins [13].  
Mantegna and others (2012) formed β-cyclodextrin and resveratrol complexes through 
ultrasound-assisted extraction from Polygonum cuspidatum.  The complexation helped to 
increase antioxidant capacity that was tested through DPPH radical scavenging and ORACFL 
test [94].  The cyclodextrins also helped to increase dispersibility and reduced time needed to 
extract resveratrol from the root.  Unmodified β-cyclodextrin was thought to be unsafe due to 
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nephrotoxicity.  Therefore, the use of modified hydroxypropyl-β-cyclodextrin as a complexation 
agent of resveratrol has also been explored [95].  This modified cyclodextrin has been found to 
form a similar 1:1 inclusion complex, but with a larger inclusion constant that indicates a greater 
inclusive potential.   The solubility and antioxidant efficacy of β-cyclodextrins and hydroxypropyl-
β-cyclodextrins were investigated.  The resveratrol-cyclodextrin complexes had a higher 
solubility and similar antioxidant activity to free resveratrol [95].  The use of hydropropyl-β-
cyclodextrin for resveratrol complexation decreased oxidation of the compound by free radicals 
and increased antioxidant activity [96].  The cytotoxicity of resveratrol complexed with β-
cyclodextrin or 2-hydroxypropyl-β-cyclodextrin was compared [97].  The complex of resveratrol 
and 2-hydroxypropyl-β-cyclodextrin showed a higher cytotoxicity against two cancer cells in 
comparison to β-cyclodextrin complexation with resveratrol.  Resveratrol was incorporated into 
the hydrophobic cavity of the cyclodextrin, therefore, hydrophobic interactions occurred between 
the compound and cyclodextrin [13].  In comparison, other encapsulation methods of 
resveratrol, such as pectinate beads, emulsions, and nanoparticles, utilize physical entrapment 
of resveratrol within a wall structure.   
2.8.2 Porous Microspheres 
Prior research utilized porous polymeric microspheres for the stabilization of resveratrol, 
looking specifically at the wetting time and cyano-functional groups [14].  The polymer particles 
are an effective means to stabilize resveratrol because they scatter light that limits light 
exposure to the compound.  Additionally, resveratrol was maintained within the microsphere 
through hydrogen bonding of the compound and cyano-functional groups of the particles.  The 
particles were produced by first forming monodisperse porous polymer particles containing 
cyano groups by dispersion polymerization.  Then, the porous particles underwent a wetting 
period of 24 hours before resveratrol was immobilized within the porous particles by dropping an 
ethanol and resveratrol mixture into the porous particle solution.  The results showed that the 
encapsulation helped to preserve 93% of the antioxidant activity and maintained bioactivity for 5 
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weeks.  Confocal laser scanning microscopy analysis confirmed that the resveratrol was evenly 
distributed within the porous particle, and it was hypothesized that hydrogen bonding helps 
provide stability to the compound.     
2.8.3 Cross-linked Chitosan 
 Cross-linked chitosan microspheres are another method that has been utilized to 
increase resveratrol stability.  Chitosan is commonly used in the food industry and is a desirable 
material for stabilization because it is non-toxic, bio-compatible and able to form films.  Cross-
linkers were used for chitosan microspheres to increase stability and control the release of the 
bioactive compounds [15].  Vanillin is an ideal cross-linker because it is generally regarded as 
safe and has bioactive properties [98, 99].  The microspheres were formed by an emulsion and 
chemical cross-linking method.  Encapsulation efficiency measurements showed 93.68% 
efficiency for the chitosan microspheres with vanillin cross-linking.  The microspheres were 
exposed to UV light for 1 hr and temperatures of 60°C and 70°C for 15 days.  The results 
support that the chitosan microspheres were able to preserve the resveratrol retention [15].   
2.8.4 Pectinate Beads 
 Calcium-pectinate beads have been used to stabilize resveratrol in order to delay the 
release of the compound from the capsule [16, 100].  This method was selected in order to 
achieve colon-specific delivery of resveratrol for the treatment of lower gastro-intestinal 
disorders.  The capsules were formed through ionotropic gelation where a resveratrol and pectin 
solution was crosslinking into a calcium, chloride, and polyethyleneimine solution.  The beads 
were then washed with water and dried.  Various parameters were altered to form capsules with 
a delayed drug release profile and high encapsulation efficiency.  It was found that 0.1% 
polyethyleneimine solution with 2 hour crosslinking time and 0.2% polyethyleneimine with 0.5 
hour crosslinking time showed an optimum drug release profile and high encapsulation 
efficiency.   
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 Zinc-pectinate beads have also been used to encapsulate resveratrol [101].  It was 
found that zinc-pectinate beads had a better delayed release than calcium-pectinate beads.  
The release of resveratrol from the beads followed zero-order kinetics, and the beads were 
stable at room temperature and 4°C.   
2.8.5 Lipid Nanoparticles and Carriers 
 Solid lipid nanoparticles and nanostructured lipid carriers have also been utilized to 
encapsulate and protect resveratrol [102].  High shear homogenization was used to produce the 
nanoparticles.  Both particles were able to decrease reactive oxygen species, but nanostructure 
lipid carriers were able to permeate deeper into the skin.  Solid lipid nanoparticles have also 
been produced through solvent diffusion-solvent evaporation [103]. Encapsulation efficiency of 
these particles was 88.9 ± 3.1%, and the in-vitro drug release was up to 120 hours.   
2.8.6 Double Emulsion 
 A water-in-oil-in-water double emulsion is where an aqueous solution is first dispersed in 
oil to form the primary emulsion which is then re-emulsified in water.  These types of double 
emulsions have been utilized to stabilize resveratrol.   A benefit of multiple emulsions is that it 
provides protection against oxidation of the target compound.  The concentration of resveratrol 
used was 200 mg/L in order to ensure dissolution of the compound. It was found that less than 
10% of the initial resveratrol content migrated to the external aqueous phase after 2 weeks of 
storage [17].  Response surface methodology was used to find the optimum ratio of primary and 
secondary emulsifiers which were as follows: 1:2 ratio of core material to coating material, 
1.25% w/v primary emulsifier concentration, 1:1.23 ratio of W/O emulsion to secondary coating 
material, and 1.21% w/v secondary emulsifier concentration [104].  Whey protein was found to 
be the most stable secondary coating material.  Further research can investigate the use of 
higher concentrations of resveratrol in emulsions and different emulsion materials in order to 
minimize the passive diffusion of resveratrol into surrounding aqueous phase.    
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2.8.7 Nanoencapsulation 
 Nanoencapsulation is when a bioactive compound is entrapped within a nano-sized 
capsule or emulsion.  Resveratrol nanoemulsions have also been utilized to increase stability 
and bioavailability of the compound [18].  Nanoencapsulation is beneficial because the small 
size is thought to increase cellular uptake.  The emulsions were composed of peanut oil and 
0.01% by weight resveratrol processed with high-pressure homogenization.  The chemical 
stability of the emulsions was tested under different storage temperatures of 4ºC, 30ºC, and 
55ºC for 30 days.  There was no cis-resveratrol detected in the encapsulated samples.  Storage 
at 4ºC degraded about 50% of resveratrol but at 30ºC and 55ºC, resveratrol was stable.  With 
an exposure to UV-C light for 2 hours, the nanoemulsions showed a decreased amount of cis-
resveratrol formation and a lower rate of degradation.  In addition, in-vitro testing of the stomach 
and small intestine processes showed that resveratrol nanoemulsions stabilized resveratrol and 
preserved the trans-isomer throughout these processes.  Nanoparticle system of resveratrol 
have also been utilized to increase the solubility while increasing the hepatoprotective effect 
[105].  Positive effects such as reduction in oxidative stress and inflammatory cytokines were 
observed from the nanoparticle system.   
2.8.8 Niosomes 
 Niosomes are non-ionic surfactant vesicles and another means by which resveratrol has 
been stabilized with a controlled release of the compound.  Niosomes were chosen for research 
because they can encapsulate hydrophilic compounds in the aqueous layer and lipophilic 
compounds on the vesicular membrane.  In addition, niosomes have a relatively low cost and 
high chemical stability in comparison to liposomes [19].  Span 60 and Span 80-cholesterol were 
the encapsulation material in the niosomes.  Span 80 niosomes had low entrapment efficiency 
while Span 60 niosomes had a higher entrapment efficiency and slower rate of release.  
Stability testing of the niosomes by light backscattering analysis showed that the Span 80 
niosomes are more stable than the Span 60 niosomes [19].    
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2.8.9 Encapsulation Combination 
 Resveratrol has been encapsulated in combination with other bioactive ingredients.  An 
oil-in-water emulsion was utilized to enable the co-delivery of compounds that differ in solubility: 
resveratrol, tributyrin and fish oil [106].  The emulsion was stabilized by heated milk protein, 
glucose and modified resistant starch.  This study forms the basis for the incorporation of 
various bioactive ingredients into a single product which can deliver similar or synergistic health 
benefits.  The stability of multiple compounds within an emulsion was not compared to a single 
compound, but future research can investigate this comparison. 
2.9 Increasing Solubility 
 Resveratrol has a limited solubility in aqueous solutions [10].  Stevioside has been 
added to resveratrol in order to increase the solubility of resveratrol in aqueous solutions [20].  It 
is hypothesized that there is an interaction between the hydrophobic core of the stevioside and 
the resveratrol thereby enhancing the solubility of the resveratrol.  The resveratrol and 
stevioside complex was 45 times more soluble in aqueous solution compared to the pure 
compound, and the addition of the complexes increased oxidative stability of soy protein 
emulsions.   
2.10 Protein Binding 
Resveratrol has been shown to bind with protein, and this interaction can further 
enhance stability of the compound.  It has been found that resveratrol interacts with β-
lactoglobulin in a 1:1 ratio.  This binding was not able to completely prevent the conversion of 
trans to cis-resveratrol, but it was capable of delaying the conversion.  In addition, the 
interaction helped to increase the solubility of resveratrol [107].  The binding between 
resveratrol and β-lactoglobulin has been found to be on the outer surface of the ligand near 
Trp19-Arg124.  The complex was stable at acidic pH with a binding constant of ~104 M-1 [108].    
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Binding between resveratrol and proteins (sodium caseinate and whey protein) have 
been investigated [109, 110].  Fluorescence has been utilized to explore binding of resveratrol.  
For sodium caseinate, the binding constant was found to be 3.7-5.1 x 105 M-1.  Hydrogen 
bonding and hydrophobic interaction are thought to be responsible for the static and dynamic 
binding between resveratrol and sodium caseinate.  The fraction of binding sites available for 
complexation was 1.20 at 25°C.  For whey protein, the binding constant was between 1.7 x 104 
– 1.2 x 105 M-1.  Whey protein and resveratrol formed a 1:1 complex, which did not affect the 
secondary structure of resveratrol.  Dipole-dipole and Van der Waal interactions were thought to 
be responsible for the binding between resveratrol and whey protein.   
2.11 Resveratrol Recovery 
Various means to increase stability of resveratrol have been developed therefore it is 
necessary to find methods to characterize the complexes or microcapsules that are formed.  
Recovery and efficiency are currently used for characterization, but different methods and 
calculations are used across research studies, making it difficult to cross compare the results.   
Nanoparticle system using polyvinyl alcohol and a cationic copolymer has been used to 
encapsulate resveratrol [105].  Resveratrol recovery was 96.3% and defined as the actual 
amount of resveratrol in the nanoparticle system compared to the theoretical maximum of 
resveratrol in the nanoparticle system.  Ethanol was used to extract resveratrol extensively from 
vanillin cross-linked chitosan microspheres, and the resveratrol recovery was 93.68% [15].  
Resveratrol recovery was also measured in resveratrol liposomes in which free resveratrol was 
first removed by dialysis and then 0.025% non-ionic surfactant, Triton X-100, was used to 
extract the resveratrol [103].  The resulting recovery was about 76%.  The decreased amount of 
recovery may be because dialysis was first used prior to the recovery analysis.  In calcium-
pectinate beads with resveratrol, the compound was extracted by pectinase enzyme and 
methanol was added to increase the solubility of the resveratrol [16].  Resveratrol recovery in 
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the calcium-pectinate beads was between 60-98%, depending on the various factors tested 
(cross-linking time, pectin:resveratrol, and polyethyleneimine concentration).   
Encapsulation efficiency is often used to compare the effectiveness of encapsulation 
methods.  This method is an indirect measurement of resveratrol content in the microcapsule as 
it takes into account the amount of resveratrol that is easily washed from the surface of the 
microcapsules rather than the amount of resveratrol extracted from the microcapsule.  When 
resveratrol was incorporated in liposomes, the technique used to produce the liposomes had a 
significant effect on encapsulation efficiency, which is explained by the following equation: 
Encapsulation efficiency = (
𝑟𝑒𝑠𝑣𝑒𝑟𝑎𝑡𝑟𝑜𝑙 𝑙𝑜𝑎𝑑−𝑟𝑒𝑠𝑣𝑒𝑟𝑎𝑡𝑟𝑜𝑙 𝑖𝑛 𝑠𝑢𝑝𝑒𝑟𝑛𝑎𝑡𝑎𝑛𝑡
𝑟𝑒𝑠𝑣𝑒𝑟𝑎𝑡𝑟𝑜𝑙 𝑙𝑜𝑎𝑑
)  (eq 1.1)    
Liposome prepared through sonication had an encapsulation efficiency of 44-56% and 
those prepared by extrusion had an encapsulation efficiency of 92-96% [111].  Also, the 
encapsulation efficiency of resveratrol nanoparticles in a methoxy poly(ethylene glycol)-
poly(caprolactone) matrix was found to be about 91% [112].  When resveratrol was 
encapsulated in zinc-pectinate or calcium-pectinate, the encapsulation efficiency was relatively 
high, between 97-99% [100, 101].  In comparison, resveratrol in solid lipid nanoparticles had an 
encapsulation efficiency between 64-89%, and nanostructured lipid carriers had an 
encapsulation efficiency between 65-77% [113].  Differences in encapsulation efficiency may be 
due to the use of different processing techniques, wall materials, and method of resveratrol 
extraction. 
2.12 Food and Non-Food Applications 
 The ultimate goal is to incorporate resveratrol into food products, but there is very limited 
research which shows application of resveratrol.  One example of this incorporation for 
functionality within a food matrix is the nanoencapsulated resveratrol was incorporated into 
hazelnut paste in order to prevent oxidation of the paste [114].  The results showed that the 
oxidation of hazelnut paste was reduced through the addition of encapsulated resveratrol. 
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Another study investigated resveratrol incorporation into edible film formation.  Chitosan and 
methylcellulose films were both used to incorporate the resveratrol.  The addition of resveratrol 
altered the film properties such as decreased ability to stretch and glossiness, and increased 
resistance to fracture, opaqueness, and antioxidant activity [22].   
 Resveratrol has also been utilized for non-food application.  Poly(L-lactic acid) films have 
been formulated with various levels of both α-Tocopherol and resveratrol.  The goal was to 
develop a functional membrane which could be used for controlled release of antioxidants in 
packaging.  The equilibrium time for the diffusion of the antioxidants into ethanol decreased with 
increased temperature.  The addition of the antioxidants to the film resulted in a decreased 
glass transition and melting temperature and increased thermal stability [115, 116].  These 
findings are significant because they provide a model for incorporation of antioxidants into 
packaging in order to reduce negative effects such as oxidation of the contents within the 
packaging through chelation of the free radicals.   
2.13 Sensory Analysis 
There is limited research in the sensory attributes of resveratrol.  One study investigated 
the sensory and chemical characteristics of Riesling and Cabernet Sauvignon wines fortified 
with two concentrations of trans-resveratrol: 20 and 200 mg/L.  Analysis was completed at 
various time points up to 58 weeks after bottling.  The Riesling wine fortified with 20 mg/L trans-
resveratrol had a significantly higher bitterness than the unfortified control, but the highest 
bitterness rating was the Riesling wine fortified with 200 mg/mL trans-resveratrol [12].  Another 
research study identified the trans-resveratrol concentrations and sensory scores of various 
wines.  The results show there was no direct correlation between the trans-resveratrol 
concentrations and the sensory scores of the wines, which were general ratings [117].  If 
specific attributes were evaluated individually, then significant differences might have been 
correlated with varying trans-resveratrol content. 
21 
 
2.14 Conclusion 
The health benefits of resveratrol provide a valid rationale to add the bioactive form of 
resveratrol into food products in order to disseminate the health benefits to the consumers.  
Current research is investigating innovative approaches to overcome the challenges of 
resveratrol incorporation into food products.   Most of these approaches are not suitable for 
mass production and have not been applied to commercial products.  Future research can 
investigate techniques such as spray drying which is widely available in the food industry and 
easy to scale up.  It is important to ensure that resveratrol is incorporated into food grade 
matrices as the intent is to incorporate the stabilized resveratrol into food products.  Protein may 
be a desirable encapsulation material for resveratrol due to the binding of resveratrol and 
protein which can further enhance stability.  The relatively low cost of protein also makes 
sodium caseinate a desirable encapsulation material.  The sensory properties of resveratrol are 
not fully understood.  Therefore, it would also be valuable if future research utilized sensory 
testing such as consumer testing to evaluate overall acceptance of products with added 
resveratrol.  Descriptive analysis could also be utilized to evaluate the effect of resveratrol on 
attribute intensity of food products.  
Overall, future research should focus on innovative processing approaches to increase 
resveratrol stability and minimize negative sensory properties of the compound.  Thereby, 
providing bioactive resveratrol to the consumer and increasing consumer acceptance of 
products with added resveratrol.   
. 
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2.15 Figures and Tables 
Table 2.1: Research supporting the health benefits of resveratrol (bw=body weight) 
In-vitro 
Author Oral Dosage Cell Model Findings 
Bertelli et al [23] 3.56 mg/L Platelet rich plasma Lowered platelet 
aggregation 
Wang et al [24] 10-1000 mM Isolated human 
platelets 
Inhibited platelet 
aggregation in 
concentration dependent 
manner 
Li et al [118] 30 µM Endothelial cells Stimulated KCa channels in 
endothelial cells  
Subbaramaiah et 
al [32] 
30 µM Human mammary 
epithelial cells 
70% decrease in basal 
production of PGE2, 
inhibited PMA-mediated 
activation of protein kinase 
C and COX-2  
Schneider et al 
[33] 
25 µM CaCo-2 cells 70% growth inhibition, 
decreased ornithine 
decarboxylase activity 
Ferry-Dumazet et 
al [34] 
100 mM Normal and leukemic 
hematopoietic cells 
Inhibited proliferation and 
induced apoptosis of cells 
Opipari et al [31] 50-200 µM Human ovarian 
carcinoma cell lines 
Induced cell death in cancer 
cells separate from 
apoptosis 
Cao and Li [119] 50-100 µM H9C2 cells Resveratrol pretreatment 
increased protection against 
cytotoxicity  
Mice/Rats 
Author Oral Dosage Animal Model Findings 
Sharma et al 
[48] 
5, 15, and 50 
mg/kg bw/day 
for 4 weeks 
Obese mice Antihyperglycemic activity 
and improvement in insulin 
levels 
Palsamy et al 
[49] 
5 mg/kg bw/day 
for 30 days 
Diabetic rats Decreased blood glucose, 
improvements in plasma 
insulin and hemoglobin 
Andersen et al 
[53] 
300 mg/kg 
bw/day for 8 
weeks 
Healthy male rats Improved insulin sensitivity  
Su et al [52] 0.1-0.75 mg/kg 
bw 
Streptozotocin-induced 
diabetic mice 
Decreased insulin secretion, 
delayed onset of insulin 
resistance, increased 
glucose uptake 
Palsamy and 
Subramanian 
[50] 
5 mg/kg bw/day Diabetic rats Decreased hyperglycemia 
and increased insulin 
secretion  
    
    
    
23 
 
    
Barger et al 
[120] 
4.9 mg/kg 
bw/day for 16 
months 
Mice on high calorie 
diet 
Prevented decline of 
cardiac function with age 
and prevented 93% of age-
induced gene expression- 
similar to results seen with 
calorie restriction 
Pearson et al 
[25] 
5-200 mg/kg 
bw/day for 6 
months 
Mice Protected against vascular 
or kidney dysfunction, 
reduced total plasma 
cholesterol and amount of 
cholesterol carried in 
lipoprotein fractions 
Bradamante et 
al [26] 
25 mg/L for 15 
days 
Rats Increased recovery at 
reperfusion and significant 
vasodilation  
Hudersen et al 
[36] 
45µg/kg bw/day 
for 60 days 
Mice Inhibited colon 
tumorigenesis  
Bishayee et al 
[37] 
50, 100, and 
200 mg/kg bw/ 
day 
Rats with liver cancer Reduced size of cancer 
nodules by inhibiting cell 
proliferation 
Jang et al [38] 1-25µM, twice a 
week for 18 
weeks 
Mouse skin cancer 
model 
Inhibited development of 
preneoplastic lesions and 
inhibit tumorigenesis 
Miura et al [1] 50 ppm for 20 
days 
Hepatoma-bearing rats Solid tumor growth and 
metastasis was suppressed, 
serum triglyceride and 
VLDL + LDL-cholesterol 
levels suppressed  
Kimura et al [39] 2.5 and 10 
mg/kg/bw 
Lung carcinoma-
bearing mice 
Reduced tumor volume and 
weight and lung metastasis  
Chen et al [40] 40 mg/kg for 28 
days 
Mice with 
neuroblastoma tumors 
Suppressed growth rate of 
subcutaneous 
neuroblastomas 
Brakenhielm et 
al [41] 
1.2 µg/day Mice Inhibited murine 
fibrosarcoma growth  
Revel et al [42] 50 mg/kg/week Balb-C mice Prevented BaP-induced 
CYP1A1 expression, related 
to prevention of lung cancer 
Schneider et al 
[43] 
0.3-0.4 
mg/mouse 
C57BL/6J-ApcMin 
male mice 
Prevented colon tumor 
formation and reduced 
formation of small intestine 
tumors by 70% 
Garvin et al [44] 100 µM MDA-MB-231 tumors in 
nude mice  
Lowered tumor growth, 
decreased angiogenesis, 
increased apoptotic index 
Zhou et al [45] 500, 1000, 1500 
mg/kg  
Gastric cancer cells in 
nude mice 
Induced apoptosis of 
transplanted tumor cells 
Tseng et al [46] 40 mg/kg/day Rats Slower tumor growth, 
increased survival of animal  
Table 2.1 (cont.) 
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Bishayee and 
Dhir [121] 
50, 100, 300 
mg/kg bw/day 
Sprague-Dawley rats Decreased incidence, 
number and multiplicity of 
visible hepatocyte nodules 
Kim et al [2] 50-500 nM Mouse model of 
Alzheimer’s disease 
Decreased 
neurodegeneration and 
prevent learning impairment 
Wang et al [55] 10-8, 10-7, 10-6 
g/kg, IV 
Cerebral artery 
occlusion model in 
Wistar rats 
Neuroprotective effect and 
NF-kappaB p65 expression 
Karuppagounder 
et al [54]  
300 mg/kg 
bw/day for 45 
days 
Mice Diminished plague 
formation, brain glutathione 
decreased and cysteine 
increased 
Gupta et al [57] 20 and 40 
mg/kg ip 
Male Wistar rats Malondialdehyde levels 
reduced showing protective 
effect against seizures 
Gupta et al [56] 20 and 40 
mg/kg ip 
Male Wistar rats Reduced incidence of 
convulsions, increased 
malondialdehyde 
Baur et al [51] 22.4 mg/kg 
bw/day 
Middle aged mice on 
high calorie diet 
Prevent harmful effects of 
high calorie intake, 
increased survival of rats on 
high calorie diet, increased 
insulin sensitivity, AMPK, 
mitochondrial number and 
improved motor function 
Martin et al [122] 5-10 mg/kg/day Rats Reduced degree of colonic 
injury, the index of 
neutrophil infiltration and 
levels of the cytokine, 
decreased PG2 and COX-2 
expression  
Lagouge et al 
[64] 
200 and 400 
mg/kg bw/day 
for 15 weeks 
Mice Increased aerobic capacity, 
consumption of oxygen in 
muscle fibers, protected 
against diet-induced obesity 
and insulin resistance 
Mizutani et al 
[123] 
1 mg/kg bw/day, 
gastric 
intubation 
Stroke prone 
spontaneously 
hypertensive rats 
Suppressed oxidative DNA 
damage and glycoxidative 
stress 
Wu et al [124] 25, 50, 100 
mg/kg, 
intraperitoneal 
Wistar rats after liver 
transplant 
Immuno-suppressive 
property and protective 
effect on hepatocytes 
Feng et al [125] 0.75-6 µM Mice Promoted lymphocyte 
proliferation and IL-2 
production  
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Liu et al [126] 2 mg/kg bw Weanling mice Shorten vaginal opening 
latency periods, enhanced 
keratinization of vaginal 
epithelium 
Giovannini et al 
[127] 
0.23 µg/kg Male Wistar rats Reduced mortality of 
ischemic rats and reduced 
renal damage, inhibited 
renal peroxidation 
Gentilli et al 
[128] 
2 mg/kg Rats Reversed hyperalgesia for 
48 hours 
Docherty et al 
[129] 
6.25 and 12.5% 
cream 
Mice Delayed or abolished 
development of herpes  
Guinea Pigs 
Author Oral Dosage Animal Model Findings 
Floreani et al 
[27] 
14 mg/kg for 16 
days 
Guinea Pigs Increased cardiac DT-
diaphorase and catalase 
activity 
Naderali et al 
[28] 
5-70 µM/L Female guinea pigs Concentration dependent 
relaxation of preconstricted 
mesenteric and uterine 
arteries  
Rabbits 
Author Oral Dosage Animal Model Findings 
Wang et al [24] 4 mg/kg bw/day Hypercholesterolemic 
rabbits 
Inhibited ADP-induced 
platelet aggregation 
Wang et al [29] 3 mg/kg bw/day Hypercholesterolemic 
rabbits 
Cardioprotective properties, 
suppressed atherosclerosis 
Elmali et al [130] 10 µM/kg for 2 
weeks, IV 
Rabbits Decreased cartilage tissue 
destruction  
Humans 
Author Oral Dosage Animal Model Findings 
Wang et al [24] 10-1000 µM Normotensive males Inhibited platelet 
aggregation in 
concentration dependent 
manner 
Kennedy et al 
[30] 
250 and 500 mg 
dose 
Healthy adults Dose dependent increase in 
cerebral blood flow and 
deoxyhemoglobin 
Wong et al [3] 30, 90, 270 mg Overweight/obese men 
or post-menopausal 
women 
Improved flow-mediated 
dilation  
Brasnyo et al [4] 10 mg/day for 4 
weeks 
Type 2 diabetic 
patients 
Reduced insulin resistance 
and urinary ortho-tyrosine 
excretion 
Brown et al [47] 0.5, 1, 2.5, 5 g/ 
day for 29 days 
Healthy adults Decrease IGF-1 and 
IGFBP-3 indicating 
chemoprotection 
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Timmers et al [5] 150 mg/day for 
30 days 
Healthy, obese men Reduced sleeping and 
resting metabolic rate, 
increased SIRT1 and PDC-
1 protein levels, decreased 
intrahepatic lipid content, 
circulating glucose, 
triglycerides and systolic 
blood pressure 
Ghanim et al [6] 40 mg/day for 6 
weeks 
Healthy, normal weight  Reduced reactive, oxygen 
species and inflammation 
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CHAPTER 3: STABILITY AND BINDING OF TRANS-RESVERATROL 
ENCAPSULATED IN A PROTEIN MATRIX PRODUCED USING SPRAY DRYING  
3.1 Abstract 
Resveratrol has demonstrated the potential to provide therapeutic and preventive 
activities against diseases such as heart disease and cancer.  The incorporation of resveratrol 
into food products would allow for wide access of these health benefits to a larger population, 
but this strategy is limited by instability of resveratrol under environmental conditions and within 
the digestive system due to the isomerization of trans-resveratrol (bioactive form) to cis-
resveratrol (bio-inactive form).  The overall goal of this research was to stabilize the bioactive 
form of resveratrol through an innovative processing approach, microencapsulation.  Trans-
resveratrol was encapsulated using whey protein concentrate or sodium caseinate, with or 
without anhydrous milk fat (AMF).  The binding of protein and resveratrol is of interest because 
it may help to stabilize resveratrol.  Resveratrol-protein binding was calculated utilizing the 
Stern-Volmer equation and the developed resveratrol binding sites equation.  The stability of 
encapsulated resveratrol was evaluated after exposure to Ultraviolet A (UVA) light and in-vitro 
digestion.  The samples were exposed to UVA light, equivalent to about 4 min of sunlight, in 
aqueous solution.  Digestive stability was assessed using a 3-phase in-vitro digestion, which 
included oral, gastric and small intestine phases. Resveratrol isomers were quantified by 
reverse phase HPLC with coulometric detection. After UVA light exposure, sodium-caseinate-
based microcapsules retained a significantly higher trans:cis resveratrol ratio (0.63) than whey-
protein-concentrate-based microcapsules (0.43) and unencapsulated resveratrol (0.49).  In 
addition, all encapsulated resveratrol had an increased digestive stability and bioaccessibility, 
respectively, in comparison to unencapsulated resveratrol (47% and 23%), with sodium 
caseinate providing a higher digestive stability (84% and 60%) compared to whey-protein-
concentrate-based microcapsules (70% and 53%).  The addition of AMF within formulations did 
not affect UVA light and in-vitro digestion stability.  In conclusion, microencapsulation with 
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sodium caseinate increased the stability of resveratrol after UVA light exposure and in-vitro 
digestion conditions.  This encapsulation-system-approach can be extended to other labile, 
bioactive polyphenols. 
Keywords: resveratrol, light stability, bioaccessibility, binding, microencapsulation 
3.2 Introduction 
Resveratrol is a polyphenol found in grapes and peanuts that has gained interest due to 
the numerous health benefits associated with this compound.  Resveratrol naturally occurs in 
low amount in red grapes (0.050 mg/100 g), red wine (0.002-0.653 mg/L) and peanuts (0.002-
.0179 mg/100 g) [1-3].  The incorporation of resveratrol into food products would allow the 
intake of biologically active dosages of resveratrol and disseminate its health benefits to a larger 
population.  The health benefits of resveratrol have been extensively investigated over the years 
in a wide range of in-vitro, pre-clinical and clinical settings.  In-vitro studies showed that 
resveratrol can lower platelet aggregation thereby decreasing cardiovascular disease and 
promoting cell death in cancer cells [4, 5].  In mice and rat models, resveratrol has been shown 
to decrease blood glucose related to diabetes and reduce plasma cholesterol linked to a 
reduction in risk of cardiovascular disease [6, 7].  Resveratrol has also been shown to decrease 
tumor growth and neurodegeneration in mice and rat models [8, 9].  In humans, several 
randomized control trials have shown the effects of resveratrol on improvement of cerebral 
blood flow and flow mediated dilation which are related to decreased risk of stroke, reduced 
insulin resistance, modulation of biochemical pathways associated with chemoprotection and 
inflammation [10-14].   
The preferred dietary form of resveratrol which has been associated with benefits is 
trans-resveratrol while the form which has questionable health benefits is cis-resveratrol.  The 
activation energy to cause the isomerization from the trans to cis-isomer was about 3.7 kcal/M 
which is a relatively small amount of energy in comparison to the activation energy to convert 
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hydrogen peroxide to oxygen, which was about 10 kcal/M [15, 16].  The conversion from the 
bioactive to bio-inactive form of resveratrol is induced by environmental conditions such as light, 
heat and pH [17-20].  Under UV light, 90.6% of trans-resveratrol in solution was converted to 
cis-resveratrol after 120 min exposure at 366 nm [17].  Also, one hour of exposure to sunlight 
resulted in 80-90% conversion of trans-resveratrol to cis-resveratrol [18].  Resveratrol is more 
stable to heat than light.  In blueberries and bilberries, 17-46% of resveratrol was degraded after 
heating for 18 min at 190°C [19].  Trans-resveratrol was stable in a range of pH conditions, from 
pH 3 to 7 for one month, but unstable at pH 12 with a half-life ranging from 10-20 hr [20].  
Another study found that trans-resveratrol was stable between pH 1-7 for 28 days and the half-
life of trans-resveratrol in pH 10 was 1.6 hr [17].  Therefore, prior research showed that 
resveratrol is unstable in certain environmental conditions. 
Digestive stability and bioaccessibility of resveratrol is another important consideration in 
order to ensure bioactivity of the compound when consumed.  An oral dose of resveratrol has 
been shown to have 70% absorption, but only trace amounts of trans-resveratrol were found in 
the blood after consumption of the compound.  Resveratrol conjugated with sulfates and 
glucuronic acid were the most common metabolites found in the urine and plasma [21].  After 
oral ingestion of resveratrol, trace amounts of the ingested resveratrol was detected in plasma 
and glucuronides were the most common form of resveratrol found in the urine [22].  Peak 
plasma concentration of trans-resveratrol was less than 2% of the oral dose and occurred about 
30 min after consumption [23].  Thus, this low digestive stability and bioavailability of resveratrol 
provides further rationale to stabilize resveratrol in order to ensure the health benefits are 
delivered to the consumer.   
Encapsulation is a viable processing method that can help to stabilize the bioactive form 
of resveratrol to environmental and digestive stress.  This technique is used to incorporate labile 
or desirable compounds into microcapsules utilizing a stable wall material.  The core ingredient 
can be protected from environmental conditions such as light, heat, pH and moisture.  In the 
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food industry, encapsulation is common for flavors, enzymes, colors, preservatives, 
antioxidants, nutrients and artificial sweeteners [24].  Encapsulation can be accomplished using 
several methods which include spray drying, liposomes, coacervation, and emulsions [25].  In 
the food industry spray drying is favored because it is economical, flexible, a continuous 
operation, and produces particles of high quality [25]. One limitation of spray drying is the wall 
material needs to be water soluble to form a solution [26].  Therefore, the selection of wall 
materials is limited by their solubility in water.  Some wall materials that have been used in 
spray drying are maltodextrins, chitosan, gum acacia and protein-lipid mixtures [26, 27].  In a 
prior study, porous polymeric microspheres were used to encapsulate resveratrol and the 
wetting time and presence of cyano-functional groups were measured.  In addition, antioxidant 
potential was measured and it was found that encapsulation helped to preserve 93% of the 
antioxidant activity and maintain the bioactivity for 5 weeks [28].  These results suggested that 
the encapsulation of resveratrol will help to stabilize the compound which in turn may enhance 
bioaccessibility.  In another study, the incorporation of resveratrol into cyclodextrin complexes 
was shown to maintain its antioxidant potential and increase solubility of the compound [29].  
Cross-linked chitosan and pectinate beads have also been utilized to encapsulate resveratrol 
[30, 31].  Results from these encapsulation studies indicate that protection of resveratrol is 
feasible, but requires optimization.  The current methods, although useful, are limited for their 
wide use in industry, since they are more appropriate for small scale production.  Protein such 
as sodium caseinate has been used in the past for encapsulation of curcumin, thymol, and a 
combination of bioactive compounds [32-34].    
In this study, spray drying with protein-based material was used as the encapsulation 
method.  Sodium caseinate and whey protein concentrate were chosen as wall materials to 
encapsulate resveratrol because they are common dairy protein utilized in the food industry and 
can be readily leveraged in many product formats, making commercialization more feasible.  In 
addition, resveratrol has been previously shown to bind with protein thereby stability of the 
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compound would be enhanced [35-37].  The binding of resveratrol to β-lactoglobulin decreased 
the isomerization of resveratrol in comparison to resveratrol not bound to protein [38].  Future 
research can utilize plant based proteins such as soy protein and pea protein, in order to make 
the encapsulation system suitable for vegans or those with sensitivities to dairy.   
The objective of this study was to evaluate the stability of the bioactive form of 
resveratrol, trans-resveratrol, against light and digestive conditions, after microencapsulation.  
The microcapsules were characterized and evaluated on the basis of stability under UVA light 
and in-vitro digestion.  The hypothesis was that microencapsulation of resveratrol within a 
protein matrix will change the stability of resveratrol in comparison to unencapsulated 
resveratrol.  The second objective of this study was to quantify the amount of binding between 
resveratrol and protein utilizing two equations and methods of calculation.  The hypothesis was 
that protein binding plays a significant role in the stability of resveratrol which can explain the 
partial recovery of resveratrol from the microcapsules.   
3.3 Materials and Methods 
3.3.1 Materials 
Trans-resveratrol was supplied by Dutch State Mines (DSM, Parsippany, NJ); its purity 
was >99% according to the manufacturer.  Oxy-resveratrol was used as an internal standard for 
high performance liquid chromatography (HPLC), and it was purchased from Cayman chemicals 
(Ann Arbor, MI); its purity was >98%.  Whey protein concentrate and sodium caseinate were 
supplied by Agropur (La Crosse, WI).  Anhydrous milk fat was purchased from Danish maid 
(Chicago, IL).  Methanol was HPLC grade and purchased from Sigma-Aldrich (St. Louis, MO).  
Materials used for the in-vitro digestion study were all purchased from Sigma-Aldrich (St. Louis, 
MO).  The filters used were 0.2 µM PTFE filter (VWR, Radnor, PA). 
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3.3.2 Methods 
3.3.2.1 Microcapsule Production 
Resveratrol microcapsules were spray dried in duplicates according to the formulas 
displayed in Table 3.1 and a schematic diagram of the microcapsule production process is 
shown in Figure 3.1.  Whey protein concentrate or sodium caseinate (Agropur Ingredients, La 
Crosse, WI) were mixed thoroughly with deionized water and heat treated at 80ºC in a water 
bath shaker (C76 Water Bath Shaker, New Brunswick Scientific, Edison, NJ) at 100 rpm for 25 
min (whey protein concentrate) or 2 hours (sodium caseinate).  The extended period of heat 
treatment of sodium caseinate was used to enable even dispersion of the protein within the 
solution.  Anhydrous milk fat (AMF) and trans-resveratrol were mixed together for 2 min at 
15,200 rpm using a hand mixer (IKA Works, Wilmington, NC).  Then, the AMF and resveratrol 
mixture was added into the protein solution.  High-pressure homogenization (APV Gaulin Inc., 
Wilmington, MA) at 55 MPa was, then, used to disperse the mixture evenly and create an 
emulsion.  The solution was passed through the homogenizer twice.  The homogenized sample 
was incubated at 45ºC in a water bath for an hour to ensure it reached temperature equilibrium 
throughout the solution.  The temperature of incubation was chosen because it is above the 
melting point of anhydrous milk fat [39]. 
A spray dryer (B-290 Buchi Corporation, New Castle, DE) was used to produce the 
encapsulated resveratrol particles.  The spray drying conditions were: inlet temperature = 
160ºC, outlet temperature = 90ºC, flow rate = 5-7 g/min, air pressure = 5 kPa and nozzle 
diameter = 0.7 mm.   Flow rate was adjusted to maintain outlet temperature.  Throughout the 
process, aluminum foil was used to protect the resveratrol from direct exposure to light.   
3.3.2.2 High-performance Liquid Chromatography 
The reverse phase high-performance liquid chromatography (HPLC) with coulometric 
detection consisted of Waters 717plus autosampler (Milford, MA) and ESA CoulArray detector 
(ThermoScientific, Sunnyvale, CA), with a Phenomenex Gemini 5u, C18, 110A, 150x4.6 mm 
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column (Phenomenex, Torrance, CA).  A binary mobile phase was used, 100% methanol and 
25 mM sodium acetate at pH 4.5 (Sigma, St. Louis, MO).  A gradient separation method was 
used starting with 30% methanol and held for 2 min.  Then, methanol was increased to 60% 
during 14 min and held for 3 min.  Then, the gradient was brought back to initial conditions over 
2 min and held constant for 2 min.  Oxy-resveratrol was used as an internal standard in HPLC 
analysis.  External standard curves were constructed with pure compounds of trans-resveratrol, 
cis-resveratrol and oxy-resveratrol.   
3.3.2.3 Moisture Content and Water Activity Measurements 
Moisture content was analyzed by HR83 Halogen Moisture Analyzer (Mettler Toledo, 
Columbus, OH), and water activity was assessed by Aqua Lab 4TE (Aqua Lab Technologies, 
Riverside, CA).  Samples from each replication of spray drying were measured in triplicates.   
3.3.2.4 Morphology and Particle Size 
Microcapsule morphology was observed through scanning electron microscope (XL30 
ESEM-FEG, FEI Company, Hillsboro, OR) at Beckmann Institute for Advanced Science and 
Technology (Urbana, IL).  Samples were coated with gold-palladium using a sputter coater 
(Desk-1 TSC, Denton Vacuum, Moorestown, NJ).  Hivac mode was used to observe the 
morphology of the resveratrol microcapsules at a voltage of 5 kV.  Particle size was estimated 
from the scanning electron microscope images. 
3.3.2.5 Microencapsulation Efficiency Measurements 
Microencapsulation efficiency (ME) was defined as the fraction of resveratrol that is not 
washed off by a solvent.  Fifty mg of resveratrol microcapsules and 5 mL methanol were 
combined in a flask and placed on a shaker at 100 rpm for 15 min at room temperature.  The 
solution was centrifuged at 1775 g with a Sorvall Legend Micro 17 centrifuge (ThermoScientific, 
Sunnyvale, CA) for 5 min at 23°C with and resveratrol content of the supernatant was measured 
by HPLC.  Samples were filtered with 0.2 µM PTFE filters before HPLC injection.  
Microencapsulation efficiency was calculated using the following equation [40]:  
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ME (%) =  
(𝒕𝒐𝒕𝒂𝒍 𝒓𝒆𝒔𝒗𝒆𝒓𝒂𝒕𝒓𝒐𝒍 −𝒔𝒖𝒓𝒇𝒂𝒄𝒆 𝒓𝒆𝒔𝒗𝒆𝒓𝒂𝒕𝒓𝒐𝒍)
𝒓𝒆𝒔𝒗𝒆𝒓𝒂𝒕𝒓𝒐𝒍 𝒍𝒐𝒂𝒅
∗ 𝟏𝟎𝟎     (eq 3.1) 
3.3.2.6 Resveratrol Recovery Measurements 
Resveratrol was extracted from the microcapsules using methanol coupled with 
sonication and volume standardization.  A Qsonica probe sonicator (Cole Parmer, Vernon Hills, 
IL) was used to sonicate 10 mg resveratrol microcapsules mixed with 4 mL methanol in a 15 mL 
round bottom tube.  The sonication probe was 3.22 mm and 50% amplitude was used.  Sample 
tubes were placed in ice water, during sonication for three cycles of 30 sec continuous 
sonication followed by 30 sec no sonication, in order to reduce heat buildup of samples.  The 
solutions were transferred to volumetric flasks and brought up to 25 mL in order to account for 
methanol evaporation during the sonication process.  Samples were filtered with 0.2 µM filters 
before HPLC analysis.  Three measurements of each spray dried replication were taken for 
resveratrol recovery.  Resveratrol recovery was calculated using the following equation: 
Resveratrol Recovery (%) =  
 𝒓𝒆𝒔𝒗𝒆𝒓𝒂𝒕𝒓𝒐𝒍  𝒆𝒙𝒕𝒓𝒂𝒄𝒕𝒆𝒅 
𝒓𝒆𝒔𝒗𝒆𝒓𝒂𝒕𝒓𝒐𝒍 𝒍𝒐𝒂𝒅
∗ 𝟏𝟎𝟎     (eq 3.2) 
3.3.2.7 Fluorescence 
Fluorescence was used to indirectly measure the binding between resveratrol and 
sodium caseinate.  The method was adapted from prior research measuring resveratrol and 
sodium caseinate binding [35].  SpectraMax M2e Microplate Reader (Molecular Devices, 
Sunnyvale, CA) was used to measure fluorescence with an excitation of 280 nm and emission 
of 350 nm.  Five replications of each sample were taken.  An aliquot of 200 µl was loaded into 
each well of a black, 96-well polystyrene plate (Costar, Corning Incorporated, Corning, NY).   
3.3.2.8 Fluorescence of Resveratrol and Ethanol 
Protein is able to fluoresce due to natural fluorophores in the protein, which are aromatic 
amino acids [41].  When protein is bound to resveratrol, the protein no longer fluoresces.  The 
change in fluoresce has been used to calculate the amount of protein bound to resveratrol [35, 
36].   Background fluorescence for all components was measured in order to control from non-
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specific signals from components in the sample other than protein. Fluorescence measurements 
ranged from 175 to 250 for various ethanol concentrations and from 110 to 250 for various 
resveratrol concentrations solubilized in 2.5% EtOH (Figure 3.2).  The average fluorescence of 
a blank well was 243 (±7).  Therefore, it was assumed that the fluorescence of ethanol and 
resveratrol alone do not significantly contribute to the overall fluorescence of the samples which 
fluorescence measurements ranged between 1200 and 2000.  Therefore, the fluorescence of 
resveratrol was not taken into account for the actual samples and it was assumed that the 
decrease in fluorescence as resveratrol concentration increase was due to binding between the 
protein and resveratrol.   
3.3.2.9 Fluorescence of Solution with Spiked Resveratrol with Various Resveratrol 
Concentrations 
Sodium caseinate solutions were prepared in the same manner as the resveratrol 
microcapsules using partial denaturation of the protein.  The resveratrol stock solution was 500 
µg resveratrol/100 µl 50% EtOH (w/w). Resveratrol was spiked into 1 mg/mL sodium caseinate 
solution at the following levels: 12.5, 25, 50, 100, and 200 µg/mL sodium caseinate solution 
(0.055, 0.110, 0.219, 0.438, and 0.876 µM).  The standard curve encompassed 8 
concentrations of sodium caseinate: 0.007, 0.016, 0.031, 0.063, 0.125, 0.250, 0.500, and 1 
mg/mL.  The ratio of resveratrol:sodium caseinate was the same as the 4.8% (dry basis, w/w) 
resveratrol microcapsule. 
3.3.2.10 Fluorescence of Microcapsules with Varying Resveratrol Concentrations 
When testing the fluorescence of microcapsules with varying resveratrol concentrations, 
standard curves were built from sodium caseinate microcapsules without any resveratrol 
content at 7 dilutions.  The concentrations of sodium caseinate in the standard curve were 
31.25, 62.5, 125, 250, 500, 1000, and 2000 µg/mL of sodium caseinate.  Resveratrol 
microcapsules were produced with various concentrations of resveratrol: 1.2%, 2.4%, 4.8%, 
9.1%, 16.7% (% in final product, w/w).  All sodium caseinate microcapsules in solution and 
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resveratrol microcapsule in solution were stored at 5°C overnight to allow protein to fully hydrate 
before fluorescence measurements.    
3.3.2.11 Stern-Volmer Equation 
The Stern-Volmer equation was developed by Otto Stern and Max Volmer and it 
indicates fluorescence quenching, which is a decrease in quantum yield of fluorophore 
fluorescence due to interaction with a quencher molecule [42, 43].  This equation was modeled 
after a simple mechanism utilizing one fluorophore, one quencher, one excited state and an 
irreversible quenching mechanism [44].  A linear plot of the equation indicates a single class of 
fluorophores while a curvature indicates complex formation of both static and dynamic binding 
[43].  This equation has been used to measure binding affinity between flavonoids and bovine 
serum albumin and resveratrol and proteins [35, 36, 43].  The Stern-Volmer equation is as 
follows:  
Stern-Volmer equation =  
𝑭𝟎
(𝑭𝟎−𝑭)
 = 
𝟏
𝒇
 + 
𝟏
𝒇
 
𝟏
𝒌𝒔𝒗
 
𝟏
[𝑸]
    (eq 3.3) 
F0 represents the fluorescence of protein without resveratrol and F represents 
fluorescence of protein with resveratrol.  Ksv is the quenching constant and f is the fraction of 
binding sites.  [Q] is the concentration of resveratrol.  The absolute concentration of protein and 
resveratrol was calculated for each sample.  The linear equation from the standard curve of 
protein was used to determine the F0 of each sample by plugging the absolute concentration of 
protein (x) and finding the fluorescence measurement (y).  The f, fraction of binding sites, was 
obtained from the best linear fit of 1/[Q] (M-1) on the x-axis and F0/(F0-F) on the y-axis (Figure 
3.3).  The concentration of sodium caseinate was multiplied by f to calculate the concentration 
of resveratrol bound to protein.    
3.3.2.12 Equation Based on Number of Resveratrol Binding Sites 
The three amino acids that are able to fluoresce are tryptophan, tyrosine and 
phenylalanine [35].  It is thought that tryptophan is mainly responsible for the fluorescence of 
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protein because tyrosine is easy quenched and phenylalanine has low quantum yield thereby 
causing emission from these amino acids to be very low [35, 41].  Therefore, tyrosine and 
phenylalanine have negligible effects on the fluorescence of proteins.  It can be assumed that 
the binding between resveratrol and tryptophan is responsible for the decrease in fluorescence 
when resveratrol is present with protein.   
The absolute amount of resveratrol and sodium caseinate was calculated for each 
sample.  The average molecular weight used for sodium caseinate was 22,814 g/M which was 
derived from the molecular weight of each fraction and the percentage of each fraction in 
sodium caseinate.  The percentage by weight of each fraction of α(S1), α(S2), β-casein and κ-
casein in sodium caseinate used for the average molecular weight were respectively: 40%, 
10%, 35%, and 15%.  Amino acid sequences were found on the Uniprot database and 
sequences from Bos taurus (bovine) were used [45].  The reference codes in the database for 
α(S1), α(S2), β-casein and κ-casein were P02662, P02663, P02666 and P02668, respectively.  
The molecular weight and number of tryptophan in each fraction were as follows: 23,000 g/M 
and 2 tryptophan for α(S1)-casein, 25,230 g/M and 2 tryptophan for α(S2)-casein, 24,000 g/M 
and 1 tryptophan for β-casein, and 19,000 g/M and 1 tryptophan for κ-casein.  The molecular 
weight, percentage of each fraction in sodium caseinate and the number of tryptophan in each 
protein fraction were taken from the literature and it is important to note that these are 
assumptions.   
The number of tryptophan in each sodium caseinate fraction along with the percentage 
of each fraction in the total protein were the factors that were taken into account when deriving 
the resveratrol binding site equation (shown in Table 3.2).  Therefore, the assumption of this 
equation is that tryptophan is the only binding site of resveratrol.  The molecular weight of each 
protein fraction was also taken into account when deriving the equation.  For each protein 
fraction, the percentage of each protein fraction in the total protein was divided by the molecular 
weight of the protein fraction and the resulting value was multiplied by the number of tryptophan 
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in the protein fraction.  The sum of this value was calculated for each protein fraction and the 
sum is the constant term in the resveratrol binding sites equation for sodium caseinate, shown 
below.   
Fraction of bound resveratrol =  
𝟔.𝟓𝟏𝟖𝟖𝑬−𝟓∗[𝑷]
[𝑹]
    (eq 3.4) 
[P] = concentration of sodium caseinate (g/L) 
[R] = molar concentration of resveratrol (M) 
Constant = 
# 𝑜𝑓 𝑡𝑟𝑦𝑝𝑡𝑜𝑝ℎ𝑎𝑛 𝑝𝑒𝑟 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒
𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑤𝑒𝑖𝑔ℎ𝑡
 = 
1.49 
22,814 𝑔/𝑀
 = 6.5188E-5 (M/g) 
The resveratrol binding sites equation was also developed for whey protein.  The 
fractions of whey protein used in the equation were β-lactoglobulin, α-lactalbumin, and serum 
albumin which were respectively: 66%, 25% and 9% of the total protein.  Molecular weights and 
number of tryptophan units in each fraction were 18,300 g/M and 2 tryptophan for β-
lactoglobulin, 14,200 g/M and 4 tryptophan for α-lactalbumin, and 66,400 g/M and 2 tryptophan 
for serum albumin [46-48].  The molecular weight, percentage of each fraction in whey protein 
and the number of tryptophan in each protein fraction were taken from the literature and it is 
important to note that these are assumptions.  The number of resveratrol binding sites for whey 
protein was calculated using the following equation: 
Fraction of bound resveratrol =   
𝟏.𝟒𝟓𝟐𝟕𝑬−𝟒∗[𝑷]
[𝑹]
   (eq 3.5)   
[P] = concentration of whey protein (g/L) 
[R] = molar concentration of resveratrol (M) 
Constant = 
# 𝑜𝑓 𝑡𝑟𝑦𝑝𝑡𝑜𝑝ℎ𝑎𝑛 𝑝𝑒𝑟 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒
𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑤𝑒𝑖𝑔ℎ𝑡
 = 
2.64 
18,173 𝑔/𝑀
 = 1.4527E-4 (M/g) 
3.3.2.13 UVA Stability Measurements 
Solutions of 10 mg resveratrol microcapsules and 4 mL NanopureTM water filtered 
through a Barnstead water purification system (Waltham, MA) were prepared in 15 mL tubes.  
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The solutions were exposed to UVA light with a wavelength of 365 nm using a Benchtop 2UV 
Transilluminator (LM-20E, Ultra-Violet Products Ltd, Upland, CA).  Samples were placed directly 
on top of the UVA light source.  This amount of UVA light translates to about 3.7 min of sunlight.   
Resveratrol was extracted from the samples, in the same way, as the resveratrol recovery 
measurements.  Resveratrol isomers were quantified on HPLC and the ratios of trans:cis 
resveratrol were calculated.   
3.3.2.14 In-Vitro Digestion Test 
 Digestive stability and bioaccessibility of trans-resveratrol was evaluated using a 3-
phase digestion model simulating oral, gastric and intestinal phases; utilizing a modified method 
from Green and others (2007) [49].  Twenty-five mg of microcapsules were used for each 
measurement and 3 measurements were taken for each spray dried replication.  The oral phase 
consisted of the addition of 8 mg of α-amylase (Sigma A3176) to each sample and tubes were 
placed in a 37ºC water bath at 90 rpm for 10 min.  Base solution for the oral phase consisted of 
potassium chloride (1.792 g/L), sodium phosphate (1.776 g/L), sodium sulfate (1.140 g/L), 
sodium chloride (0.596 g/L) and sodium bicarbonate (3.388 g/L).  For the gastric phase, 20 mg 
of pepsin (Sigma P7125, final concentration 0.5 g/L in sample) in 2 mL of 0.1 M HCl was added 
and samples were acidified to pH 2.5 using 1 M HCl (~200 µl).  Sample volumes were brought 
up to 40 mL with saline and tubes were placed in a shaking water bath for 1 hr at 37ºC.  For the 
intestinal phase, 2 mL 0.1 M NaHCO3 solution containing 40 mg pancreatin (Sigma P1750, final 
concentration 0.8 g/L) and 20 mg lipase (Sigma L3126, final concentration 0.4 g/L) and 3 mL 0.1 
M Na HCO3 solution containing 120 mg bile (Sigma B8631, final concentration 1.8 g/L) were 
added to each sample.  The pH of samples was adjusted to 6.5 using 1 M NaHCO3 (<50 µl, if 
needed) and sample volumes brought up to 50 mL with saline (0.9% NaCl).  Samples were 
placed in the water bath for 2 hr at 37ºC.  An aliquot of the resulting sample was taken and this 
was referred to as the digesta.  In order to isolate the aqueous fraction, the remaining sample 
was centrifuged at 10,000 g for 1 hr (Allegra X-22R, Beckman Coulter, Brea, CA) and filtered 
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with 0.2 µM filters.  Samples were placed immediately on ice between phases and blanketed 
with nitrogen before incubations and storage to minimize oxygen in the sample tubes.  Digestive 
stability is the amount of resveratrol left in the sample after the completion of the small intestinal 
phase (digesta) in comparison to the amount of trans-resveratrol loaded into the microcapsules 
(resveratrol load). 
Digestive stability (%) = 
𝒕𝒓𝒂𝒏𝒔−𝒓𝒆𝒔𝒗𝒆𝒓𝒂𝒕𝒓𝒐𝒍 𝒊𝒏 𝒅𝒊𝒈𝒆𝒔𝒕𝒂
𝒓𝒆𝒔𝒗𝒆𝒓𝒂𝒕𝒓𝒐𝒍 𝒍𝒐𝒂𝒅
 * 100%   (eq 3.6) 
Bioaccessibility is the experimentally determined estimate of what is available for intestinal 
absorption by virtue of being solubilized in the continuous aqueous fraction of the digesta.  This 
was the amount of resveratrol partitioned into the micellar fraction, after high speed 
centrifugation at 10,000 x g for 60 min.  It was the comparison of the amount of trans-resveratrol 
in the aqueous fraction in comparison to the resveratrol load.   
Bioaccessibility (%) = 
𝒕𝒓𝒂𝒏𝒔−𝒓𝒆𝒔𝒗𝒆𝒓𝒂𝒕𝒓𝒐𝒍 𝒊𝒏 𝒂𝒒𝒖𝒆𝒐𝒖𝒔 𝒇𝒓𝒂𝒄𝒕𝒊𝒐𝒏
𝒓𝒆𝒔𝒗𝒆𝒓𝒂𝒕𝒓𝒐𝒍 𝒍𝒐𝒂𝒅
 * 100%  (eq 3.7) 
HPLC was utilized to measure the amount of trans-resveratrol in each digestive fraction.  
Samples were filtered with 0.2 µM filters (VWR, Radnor, PA) before HPLC analysis. 
3.3.2.15 Statistical Analysis  
Formulations presented in Table 3.1 were spray dried in duplicates.  Microsoft Excel 
(Microsoft, Redmond, WA) was used to analyze data related to resveratrol-protein binding which 
includes the equation of the best fit line of fluorescence data, calculating percentage of bound 
resveratrol, and fraction of binding sites.  Microencapsulation efficiency, resveratrol recovery, 
UVA stability, digestion analysis, moisture content and water activity were completed in 
triplicates.  The software, Statistical Analysis System (Cary, NC), was used to conduct analysis 
of variance (ANOVA, p<0.05) and least significant difference (LSD) testing on the data.   
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3.4. Results and Discussion 
3.4.1 Moisture Content and Water Activity Measurements 
Moisture content and water activity of the microcapsule formulations are represented in 
Table 3.3.  Moisture content was not significantly different between spray dried replications.  
When whey protein was used to encapsulate avocado oil through spray drying, the moisture 
content ranged from 2.24-2.89% with a standard deviation up to about 1% [50].  These results 
were comparable to the moisture content found in our study when using whey protein 
concentrate with the inclusion of fat (2.36-2.54%).  Water activity of all resveratrol microcapsule 
formulations varied between 0.06-0.15.  This range of water activity was lower than that found 
for bifidobacteria encapsulated in whey protein-based microcapsules in which the water activity 
was between 0.14-0.18 [51].  The variation in water activity may be attributed to the different 
encapsulation technique (spray drying vs. freeze drying) and the type of core material, as the 
optimum condition for bifidobacteria is a water activity between 0.11-0.22 [52].    
3.4.2 Morphology and Particle Size 
 Scanning electron microscope (SEM) images of resveratrol microcapsules showed that 
the microcapsules had a particle size between 1-20 µm and they were non-spherical (Figure 
3.4).  They appear to have a wrinkled or dehydrated appearance which may be attributed to the 
nature of the spray drying process when using protein as an encapsulation matrix.   Void space 
was created at the core of the spray dried particle due to expansion and shrinkage during the 
spray drying process.  Other research supports that spray drying with protein as a wall material 
will produce this type of morphology [53, 54].  Morphology images of dried egg and skimmed 
milk showed similar morphology as the resveratrol microcapsules [53].  Skimmed milk particles 
were found to be hollow with an outer shell thickness between 20-60 µm.  In addition, 
morphology of pea protein microcapsules produced through spray drying had a similar 
morphology to the resveratrol microcapsules [54]. 
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3.4.3 Microencapsulation Efficiency 
Microencapsulation efficiency measurements of the samples are shown in Table 3.4.  
Whey-protein-concentrate-based microcapsules had a higher microencapsulation efficiency 
than sodium-caseinate-based microcapsules (p<0.05).  Furthermore, the inclusion of anhydrous 
milk fat led to a decrease in microencapsulation efficiency (6%) in whey-protein-based 
microcapsules only (p<0.05).   
The microencapsulation efficiency of resveratrol was studied within liposomes and a 
significant difference was found between the encapsulation methods tested [55].  Liposomes 
prepared through sonication had 44-56% microencapsulation efficiency and those prepared 
through extrusion had 92-96% microencapsulation efficiency.  The low microencapsulation 
efficiencies of liposomes produced through sonication may have been due to the high shear 
force used in this processing method which probably resulted in resveratrol movement out of the 
microcapsule.  Microencapsulation efficiency of resveratrol within a solid lipid nanoparticle was 
64-89% and within a nanostructured lipid carrier was 65-77% [56].  Our results were similar to 
those found in the nanoparticles and nanostructured lipid carriers.  Differences in 
microencapsulation efficiencies between studies may be due to the level of solubility of 
resveratrol in different mediums and the partitioning of resveratrol between these mediums. 
3.4.4 Resveratrol Recovery 
  Recovery of resveratrol using sonication and methanol was not complete.  Table 3.4 
shows the recovery for most formulations was less than 66% after probe sonication.  Therefore, 
this suggests that the decreased recovery may be attributed to nonspecific binding between the 
resveratrol and protein.  Prior research supported that proteins can bind with resveratrol.  The 
binding constants of whey protein and sodium caseinate with resveratrol are 1.7 x 104 - 1.2 x 
105 M-1 and 3.7 x 105 M-1 - 5.1 x 105 M-1, respectively [35, 36].  The binding between resveratrol 
and whey protein was thought to be due to dipole-dipole and Van der Waal forces [36].  For 
sodium caseinate, hydrogen bonding and hydrophobic interactions were thought to be 
50 
 
responsible for resveratrol-protein-binding [35].  The binding between resveratrol and sodium 
caseinate was investigated, utilizing two equations: Stern-Volmer equation and resveratrol 
binding sites equation.  It was thought that the low resveratrol recovery from the microcapsules 
was attributed to resveratrol-protein binding.   
3.4.4.1 Fluorescence 
Fluorescence of the proteins decreased as the resveratrol concentration in the sample 
increased (Figure 3.5).  The change in fluorescence indicated that the resveratrol was binding 
with the protein and binding increased as resveratrol concentration increased.   
3.4.4.2 Estimated Resveratrol Binding Using Stern-Volmer Equation 
The increased stability of encapsulated resveratrol may decrease the recovery of 
resveratrol from the microcapsules.  It was thought that the binding between resveratrol and 
protein inhibits the compound from being fully recovered from the microcapsules using only 
probe sonication.  Resveratrol may be fully extracted from the microcapsules using enzymes 
and other physical treatments.  Thereby, the quantification of binding between resveratrol and 
protein is necessary in order to provide an explanation for the limited recovery of resveratrol 
using only probe sonication. 
The Stern-Volmer equation (eq 3.3) was used to calculate resveratrol-protein binding.  
An f value of 0.35 and Ksv of 22,727 was obtained when fluorescence was measured of the 
resveratrol microcapsules (Table 3.6).  When sodium caseinate solutions were spiked with 
resveratrol and Stern-Volmer equation used, it was calculated that the f and Ksv values were 
1.04 and 9,640, respectively.  An f value of 1.20 and Ksv of 29,600 were reported in the literature 
for sodium caseinate solutions with spiked resveratrol [35].  The f value reported in the literature 
was close to that of our sodium caseinate solutions with spiked resveratrol but different from 
that of our resveratrol microcapsules with varying resveratrol concentrations.     
The f value is a component in the calculation for bound resveratrol, therefore, the 
amount of bound resveratrol in microcapsules was significantly less than in protein solutions.  
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An f value slightly greater than 1 may be due to a combination of dynamic and static quenching 
[35].  Therefore, it was assumed that the lower f value in the resveratrol microcapsules indicated 
that there was limited dynamic binding while the higher f value in the sodium caseinate solutions 
indicated a higher dynamic binding.  In the protein solutions, there was more fluidity of 
components within the matrix therefore providing more opportunity for binding.  In comparison, 
there was less fluidity within the microcapsules thereby resulting in less binding between the 
protein and resveratrol.  The resveratrol microcapsules also had a lower R2 than the sodium 
caseinate solutions which suggests that the additional processing in these samples may result 
in a higher variation in the fluorescence measurements of the samples.  These results suggest 
that the Stern-Volmer equation was more suitable to compare samples with both dynamic and 
static binding.  This is reasonable as the equation was originally modeled for dynamic binding 
[57, 58].  Also, it would not be appropriate to compare samples of different nature (microcapsule 
vs. protein solution).  Although the encapsulated resveratrol was mixed with water, it was 
assumed that the resveratrol and protein generally remain within the microcapsule as 
resveratrol has limited solubility in aqueous solution.    
3.4.4.3 Effect of pH on Stern-Volmer Calculations 
Fluorescence measurements of the resveratrol microcapsules were measured with and 
without pH adjustment. The pH of samples without buffer or pH adjustment ranged from 6.4 to 
7.3.  Phosphate buffered saline, 1x pH 7.4 (Quality Biological Inc, Gaithersburg, MD) was used 
to buffer protein standards and resveratrol microcapsule samples.  The pH was adjusted to 7.4 
± 0.05 with 1 M HCl and 1 M NaHCO3.  
 The fraction of binding sites and percent bound resveratrol were 0.35 and 6% with pH 
adjustment and 0.44 and 8% without pH adjustment (Table 3.7).  Fluorescence procedures 
utilized by other research groups to measure protein and resveratrol binding adjusted pH of 
samples to be pH 7 [36, 37], while other research groups did not control the pH [35].  This 
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suggests that pH may not be a significant factor in samples within the narrow pH range of 6.4 - 
7.3.   
3.4.4.4 Estimated Resveratrol Binding Using Resveratrol Binding Sites Equation 
Results from using the derived resveratrol binding sites equation to calculate the amount 
of maximum binding potentials of resveratrol are shown in Figure 3.6.  According to the 
resveratrol binding sites equation, all the resveratrol in the 1.2% resveratrol microcapsule for 
both whey protein concentrate and sodium caseinate had the potential to bind to the protein.  
The equation estimated that there was more bound resveratrol in whey-protein-concentrate-
based microcapsules because there are more tryptophan binding sites per mole in comparison 
to sodium caseinate.   
The structures of whey protein and sodium caseinate may also play a role in resveratrol-
protein binding as it affects the ability of binding sites to be accessed by resveratrol.  Sodium 
caseinate has a more open configuration without any tertiary structure while whey protein is a 
globular protein [59-61].  Although sodium caseinate may have few tryptophan per protein 
molecule, the protein structure may allow a higher percentage of these binding sites to be 
accessible.  In comparison, whey protein has more tryptophan per protein molecule but less of 
these binding sites are accessible to bind with resveratrol.   
3.4.4.5 Compare the Resveratrol Binding Using Stern-Volmer Equation and Resveratrol 
Binding Sites Equation 
Amount of bound resveratrol (%) = 
[𝑃]∗ 𝑓
[𝑅]
 * 100%   (eq 3.8) 
[P] = molar concentration of protein (M) 
[R] = molar concentration of resveratrol (M) 
f = fraction of binding sites available  
 The amount of bound resveratrol was compared using the microcapsules containing 
4.8% resveratrol (dry basis, w/w).  The calculation of maximum binding potential of resveratrol 
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by tryptophan in the microcapsule differs significantly when using the Stern-Volmer equation (eq 
3.3) (6%) and the resveratrol binding sites equation (eq 3.4) (26%) (Table 3.8).  The difference 
in the results may be due to the fact that one result was experimentally determined while the 
other solely accounts for the number of tryptophan in the protein.  In addition, the resveratrol 
binding sites equation is the maximum binding potential of resveratrol to tryptophan while the 
Stern-Volmer equation is not an indication of the maximum binding potential.  In addition, the 
molecular weight of the protein fractions are assumptions as crude systems were used to 
measure resveratrol-protein binding.  The Stern-Volmer equation compares change in 
fluorescence of the protein in the presence and absence of the resveratrol.  The change in 
fluorescence was assumed to be due to binding of the protein that prevents the protein from 
fluorescing.  The resveratrol binding sites equation solely accounts for the number of tryptophan 
as it is the main amino acid responsible for binding with resveratrol [35].    
 The assumptions of the resveratrol binding site equation were that 1) one resveratrol 
molecule binds with each binding site, 2) only tryptophan is the binding site for resveratrol and 
3) all tryptophan in the protein are available for binding.   
3.4.4.6 Total Resveratrol Accounted For 
Table 3.9 shows the total resveratrol accounted for according to resveratrol binding sites 
equation for both sodium caseinate and whey-protein-concentrate-based microcapsules.  The 
compilation of both experimentally determined resveratrol recovery data and the estimation of 
bound resveratrol from the resveratrol binding sites equation indicate that sodium caseinate 
microcapsules have approximately 90% resveratrol accounted for and whey protein concentrate 
microcapsules have about 97.5% resveratrol accounted for.  The resveratrol that was 
unaccounted for may be lost in processing of the microcapsules broken down to metabolites. 
3.4.4.7 Binding of Resveratrol and Protein 
The stability of resveratrol was enhanced by the binding of resveratrol and protein.  It 
was found that specifically β-lactoglobulin, can form a 1:1 complex with resveratrol, binding to 
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the surface of the β-lactoglobulin with a binding constant of 104-106 M-1.  The binding delayed 
the conversion of trans to cis-resveratrol, thereby increasing the photo stability of resveratrol 
[37].  Molecular docking research showed that the resveratrol was bound to the surface of β-
lactoglobulin by two hydrogen bond interactions [62].  One study compared different fractions of 
whey protein and found that whey protein binds with resveratrol in a 1:1 complex, similar to the 
results found of β-lactoglobulin [36].  The ratio of bound whey protein:resveratrol was 
determined from fluorescence measurements.  The binding constant of resveratrol and whey 
protein was between 1.7 x 104 to 1.2 x 105 M-1 [36].  Binding between whey protein and 
resveratrol was thought to be dipole-dipole and Van der Waal interactions.  In sodium caseinate, 
resveratrol was found to have a binding constant of 3.7 to 5.1 x 105 M-1.  Binding between 
sodium caseinate and resveratrol was thought to be hydrogen bonding and hydrophobic 
interaction [35].  The binding constant of resveratrol with α-casein was 1.9 x 104 M-1 and with β-
casein it was 2.3 x 104 M-1 [63].   
 Our results differ from the literature as sodium caseinate was found in the literature to 
have a higher binding constant than whey protein.  In our results, we found that there was more 
potential for resveratrol to bind with whey protein than sodium caseinate.  The difference in 
bound resveratrol was most likely because the resveratrol binding sites equation solely takes 
into account the number of tryptophan within a protein.  In addition, different testing conditions 
such as temperature and ratio of resveratrol:protein were used among different researchers.   
Our sample matrix was resveratrol microcapsules and due to the lack of dynamic binding in this 
matrix, it may not be accurate to cross-compare our results to other research studies.   
In addition, nonpolar interactions may be attributed to the binding between resveratrol 
and protein.  These interactions have been found between resveratrol and human islet amyloid 
polypeptide oligomers and fibrils [64]. 
 Overall, this research study showed a significant difference between the binding 
calculations of the Stern-Volmer equation and the resveratrol binding sites equation.  The Stern-
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Volmer equation was experimentally determined through fluorescence while the resveratrol 
binding sites equation takes into account the number of tryptophan in the protein.  Whey protein 
was shown to have a higher binding potential than sodium caseinate according to the 
resveratrol binding sites equation, in order to increase resveratrol stability.   
3.4.5 UVA Stability 
 The results from UVA stability tests are in the form of trans:cis resveratrol ratio as shown 
in Table 3.4.  Absolute amounts of trans- and cis-resveratrol in the samples were estimated 
according to the ratios found after UVA light exposure (Table 3.5).  Ratios of trans:cis 
resveratrol were used to evaluate the stability because not all the resveratrol was able to be 
recovered after the extraction.  Therefore, the comparison of trans-resveratrol concentration 
between formulations would not be a true representative of UVA stability.  For this comparison, 
it was assumed that the unrecovered resveratrol existed in the same trans:cis resveratrol ratio 
as what was extracted.  The results showed that sodium-caseinate-based microcapsules was 
able to preserve the trans:cis resveratrol ratio in a higher proportion than the whey-protein-
concentrate-based microcapsules and unencapsulated resveratrol.  This showed that sodium 
caseinate is a better encapsulation material to maintain resveratrol bioactivity.  UV stability of 
resveratrol encapsulated with chitosan cross-linked with vanillin has been investigated [31].  The 
recovery of trans-resveratrol after UV exposure of these microcapsules was about 78%.  The 
amount of recovered trans-resveratrol was maintained in the bioactive form and extracted from 
the microcapsule.  The UV light used in this study was 16 W at about 20 cm distance but the 
condition used in our study was 8 W at 0 cm distance from the light source.  The difference in 
power and distance of the sample from the UV source may be attributed to differences seen in 
the retention of trans-resveratrol between the studies but it is difficult to cross-compare the 
studies because different UV light sources were used.   
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3.4.6 In-Vitro Digestions 
Digestive stability of trans-resveratrol within the microcapsules (68-86%) was higher 
than the unencapsulated resveratrol (47%) (p<0.05, Figure 3.7).  The digestive stability was 
generally higher in the sodium-caseinate-based microcapsules in comparison to the whey-
protein-concentrate-based microcapsules.  In terms of bioaccessibility, all microcapsule 
formulations increased bioaccessibility of resveratrol (48-60%) in comparison to unencapsulated 
resveratrol (23%) (Figure 3.8).  This suggests that the encapsulation of resveratrol decreased 
the isomerization or degradation of resveratrol throughout digestion as evaluated by the in-vitro 
digestion.  Encapsulation may also have increased the solubility of resveratrol thereby playing a 
factor in increased in-vitro stability.  Sodium caseinate proved to be a better encapsulation 
matrix than whey protein concentrate for resveratrol and the inclusion of anhydrous milk fat in 
the formulation did not significantly affect stability.  Therefore, it is not necessary to include 
anhydrous milk fat in the formulation.   
Encapsulation can aid in the protection of resveratrol throughout the digestion system 
and enable targeted release of the compound in the human body.  Our results suggested that 
the bioavailability would be increased and degradation of resveratrol during digestion would be 
decreased.  This assumption is supported by the higher bioaccessibility and digestive stability of 
the encapsulated resveratrol compared to unencapsulated resveratrol within the 3-phase in-vitro 
digestion model.            
 When humans were fed 25 mg resveratrol orally, 70% of the compound was absorbed 
but only trace amounts of trans-resveratrol were detected in the plasma.  Most of the trans-
resveratrol was metabolized to sulfates and glucuronic acid found in the urine [21].    Research 
by Azorin-Ortuno and others (2011) supported this theory as 50% of trans-resveratrol and 
derived metabolites administered to pigs was found in the jejunum and ileum of the small 
intestine [65].  Therefore, stabilization of resveratrol in the digestive tract is an important 
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consideration in order to deliver the compound in a bioactive form to the targeted part of the 
digestive tract.   
3.5 Conclusions 
The resveratrol binding sites equation provides simple quantification of bound resveratrol 
without experimentation.  This method can be extended to other polyphenols or bioactive 
compounds which bind to sodium caseinate and whey protein concentrate in a similar manner 
as resveratrol. The equation can also be altered to fit the parameters of other types of protein 
where the amino acid composition is known.   The use of fluorescence and the resveratrol 
binding sites equations have limitations as they only take into account binding of resveratrol with 
aromatic amino acids.  Further research can investigate if resveratrol can bind with additional 
amino acids, aside from tryptophan or other components of the protein.  This understanding will 
provide a more accurate estimate of bound resveratrol and allow comparison of different 
proteins as an encapsulation material.   
The combination of spray drying as an encapsulation method and sodium caseinate as 
an encapsulation matrix proved to be an effective approach to produce stabilized resveratrol.  
This processing technique and encapsulation material are desirable as they are widely available 
at relatively low cost.  Thus, sodium-caseinate-based microcapsules can be further investigated 
to increase stability in UV light and in-vitro digestion.  One limitation of the findings was that the 
microscopic images of the resveratrol microcapsules showed the morphology was non-
spherical.  Future research can investigate the incorporation of specific components, such as 
plasticizers, in resveratrol microcapsules and their effect on morphology and stability of 
resveratrol within the microcapsule.  The encapsulation-system-approach utilized in this 
research can be extended to other labile, bioactive compounds such as quercetin or lutein to 
increase their stability.   
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3.6 Figures and Tables 
Figure 3.1: Schematic diagram of resveratrol microcapsule production 
 
 
 
 
 
 
 
  
Inlet temp. = 160ºC 
Outlet temp. = 90ºC 
Flow rate = 5-7 g/min 
Air pressure = 5 kPa  
Nozzle diameter = 0.7 mm 
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Figure 3.2: Fluorescence measurements from spectrofluorometer of: A) Ethanol 
concentrations without resveratrol, B) Various resveratrol concentrations solubilized in 
2.5% ethanol 
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Figure 3.3: Best fit linear line of 1/[Q] (M-1) and F0/(F0-F), components of the Stern-Volmer 
equation.  Fraction of binding sites calculated by 1/intercept of best fit line.    
 
 
1/[Q] (M-1) and F0/(F0-F) from Stern-Volmer equation (eq 3.3) 
[Q]: Resveratrol concentration 
F0: Fluorescence measurement without resveratrol 
F: Fluorescence measurement in the presence of resveratrol  
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Figure 3.4: Scanning electron microscope images of resveratrol microcapsules 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AMF: Anhydrous milk fat 
SCAMF: Sodium caseinate with AMF, SC: Sodium caseinate without AMF 
WPCAMF: Whey protein concentrate with AMF, WPC: Whey protein concentrate without AMF 
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Figure 3.5: Fluorescence measurements of sodium caseinate solutions with 
various resveratrol concentrations showing that as resveratrol increases, 
fluorescence decreases 
 
  
y = 18773x-0.708
R² = 0.9903
0
500
1000
1500
2000
2500
3000
3500
0 50 100 150 200 250
F
lu
o
re
s
c
e
n
c
e
 M
e
a
s
u
re
m
e
n
t
Resveratrol Concentration (µg/mL)
63 
 
Figure 3.6: Maximum binding potential of resveratrol in sodium-caseinate and 
whey-protein-concentrate-based microcapsules with various resveratrol 
concentrations according to resveratrol binding sites equation 
 
 
WPC: Whey-protein-concentrate-based microcapsules 
SC: Sodium-caseinate-based microcapsules 
  
100% 100%
58%
29%
15%
100%
52%
26%
13%
7%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
1.2% 2.4% 4.8% 9.1% 16.7%
M
a
x
im
u
m
 B
in
d
in
g
 P
o
te
n
ti
a
l 
(%
)
Resveratrol Concentration in Experimental Design (dry basis, w/w)
WPC
SC
64 
 
Figure 3.7: Digestive stability (%) of resveratrol in microcapsules after 3-phase in-
vitro digestion 
 
 
 
Values represent average of two spray dried replicates 
Same letters represent not significantly different values (p<0.05, ANOVA and LSD) 
Anhydrous milk fat (AMF); sodium caseinate with AMF (SCAMF); sodium caseinate without 
AMF (SC); whey protein concentrate with AMF (WPCAMF); whey protein concentrate without 
AMF (WPC) 
* Unencapsulated resveratrol 
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Figure 3.8: Bioaccessibility (%) of resveratrol in microcapsules after 3-phase in-
vitro digestion 
 
 
Values represent average of two spray dried replicates 
Same letters represent not significantly different values (p<0.05, ANOVA and LSD) 
Anhydrous milk fat (AMF); sodium caseinate with AMF (SCAMF); sodium caseinate without 
AMF (SC); whey protein concentrate with AMF (WPCAMF); whey protein concentrate without 
AMF (WPC) 
* Unencapsulated resveratrol 
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Table 3.1: Formulas for resveratrol microcapsules using sodium caseinate and 
whey protein concentrate, with and without anhydrous milk fat 
  
Component SCAMF SC WPCAMF WPC 
Sodium Caseinate 80 g 80 g 0 g 0 g 
Whey Protein Concentrate 0 g 0 g 80 g 80 g 
Anhydrous milk fat 100 g 0 g 100 g 0 g 
Deionized Water 920 g 920 g 920 g 920 g 
Trans-Resveratrol (% by 
total solids) 
9 g (4.8%) 4 g (4.8%) 9 g (4.8%) 4 g (4.8%) 
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Table 3.2: Percent of total protein, molecular weight, and number of tryptophan 
for each protein fraction in A) sodium caseinate and B) whey protein concentrate 
A) 
Protein Fraction 
% of total 
protein by 
weight 
Molecular Wt # of tryptophan 
αS1-casein 40 23000 2 
αS2-casein 10 25230 2 
β-casein 35 24000 1 
κ-casein 15 19000 1 
  Weighted Avg: 1.49 
 
B) 
Protein Fraction 
% of total 
protein by 
weight 
Molecular Wt # of tryptophan 
B-lactoglobulin 66 18300 2 
alpha-lactalbumin 25 14200 4 
serum albumin 9 66400 2 
  Weighted Avg: 2.64 
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Table 3.3: Percent moisture content and water activity, mean (±SD), of resveratrol 
microcapsules 
 
Sample Moisture Content Water Activity 
SCAMF R1 2.42a 0.12b 
SCAMF R2 2.17ab 0.10d 
SC R1 2.12ab 0.07g 
SC R2 2.35a 0.11c 
WPCAMF R1 2.36a 0.15a 
WPCAMF R2 2.54a 0.06h 
WPC R1 1.73bc 0.09e 
WPC R2 1.51c 0.07f 
 
(±standard deviation), R = replication 
AMF: Anhydrous milk fat 
SCAMF: Sodium caseinate with AMF, SC: Sodium caseinate without AMF 
WPCAMF: Whey protein concentrate with AMF, WPC: Whey protein concentrate without AMF 
Same letters within each column represent not significantly different values after ANOVA and 
LSD (p<0.05). 
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Table 3.4: Efficiency of microencapsulation, recovery and UVA stability ratio 
(Trans:Cis Ratio) of resveratrol in microcapsules  
 
Sample Efficiency Recovery 
 
UVA Stability  
SCAMF 68%c 66%b 0.62a 
SC 68%c 62%b 0.64a 
WPCAMF 77%b 42%c 0.46b 
WPC 83%a 37%c 0.39b 
Control --- 93%a 0.49b 
 
Values represent average of two spray dried replicates  
Same letters within each column represent not significantly different values after ANOVA and 
LSD (p<0.05). 
Anhydrous milk fat (AMF); sodium caseinate with AMF (SCAMF); sodium caseinate without 
AMF (SC); whey protein concentrate with AMF (WPCAMF); whey protein concentrate without 
AMF (WPC); Unencapsulated resveratrol (Control) 
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Table 3.5: Estimated absolute values of trans- and cis-resveratrol in the 
resveratrol microcapsules after UVA light testing 
Sample Trans:Cis 
resveratrol Ratio 
Trans-resveratrol 
(µg) 
Cis-Resveratrol (µg) 
SCAMF 0.62 184 296 
SC 0.64 187 293 
WPCAMF 0.46 151 329 
WPC 0.39 135 345 
Control 0.49 158 322 
 
Estimated absolute values are calculated according to the resveratrol load and ratio of trans:cis 
resveratrol after UVA light testing at 365 nm for 1 hour.  Resveratrol load in 10 mg of 
microcapsules is 480 µg resveratrol. 
AMF: Anhydrous milk fat, Control: Unencapsulated resveratrol 
SCAMF: Sodium caseinate with AMF, SC: Sodium caseinate without AMF 
WPCAMF: Whey protein concentrate with AMF, WPC: Whey protein concentrate without AMF 
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Table 3.6:  Comparison of the fraction of binding sites (f), quenching constant of sodium 
caseinate by resveratrol (Ksv) and correlation coefficient (R2) of resveratrol 
microcapsules, sodium caseinate solutions with spiked resveratrol, and values reported 
in the literature (similar procedure to sodium caseinate solutions with spiked resveratrol) 
 
Sample f Ksv R2 
Resveratrol microcapsules 0.35 22,727 0.897 
Sodium caseinate solution 
with spiked resveratrol 
1.04 9,640 0.997 
Literature [32] at 25ºC 1.20 29,600 0.978 
 
Values are components of the Stern-Volmer equation 
 
 
 
 
 
 
Table 3.7:  Fraction of binding sites (f) and bound resveratrol in resveratrol 
microcapsules with and without pH adjustment to pH 7.4 
 
Sample f Bound Resveratrol (%) 
With pH adjustment (pH = 7.4) 0.35 6% 
Without buffer or pH adjustment 
(~pH 6.4-7.3) 
0.44 8% 
 
f value is component of the Stern-Volmer equation 
 
 
  
72 
 
Table 3.8:  Estimated maximum binding potential of resveratrol by tryptophan in 
microcapsule with various resveratrol concentrations using number of resveratrol 
binding sites in the protein  
 
Sample 
Maximum Binding 
Potential of Resveratrol 
by Tryptophan (w/w %) 
Stern-Volmer Equation – Resveratrol 
Microcapsules 
6% 
Stern-Volmer Equation – Sodium Caseinate 
Solution with Spiked Resveratrol* 
18% 
Resveratrol Binding Site Equation 26% 
* Ratio of resveratrol:sodium caseinate was the same as the 4.8% (dry basis, w/w) resveratrol 
microcapsule 
 
 
 
 
Table 3.9: Total resveratrol accounted for according to resveratrol binding sites equation 
for 4 resveratrol microcapsule formulations 
 
Sample Recovery
1
  
Maximum Binding 
Potential by Tryptophan
2
 
Total Resveratrol
3
 
SCAMF 66% 26% 92% 
SC 62% 26% 88% 
WPCAMF 42% 58% 100% 
WPC 37% 58% 95% 
 
1Experimental resveratrol recovery using probe sonication 
2Maximum binding potential of resveratrol by tryptophan according to resveratrol binding sites 
equation 
3Total resveratrol (%) = Resveratrol recovery (%) + Maximum binding potential of resveratrol by 
tryptophan (%) 
SCAMF: sodium caseinate w/anhydrous milk fat microcapsule 
SC: sodium caseinate w/o anhydrous milk fat microcapsule 
WPCAMF: whey protein concentrate w/anhydrous milk fat microcapsule 
WPC: whey protein concentrate w/o anhydrous milk fat microcapsule 
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CHAPTER 4: EFFECT OF PLASTICIZERS ON STABILITY OF ENCAPSULATED 
RESVERATROL 
4.1 Abstract 
 Microencapsulation in a sodium-caseinate-based microcapsule has been shown to 
provide higher UV stability of resveratrol compared to unencapsulated resveratrol, in our prior 
research (Chapter 3).  Scanning electron microscope images showed that the morphology of 
the microcapsules was non-spherical, and this provided rationale to enhance the spherical 
nature of the microcapsules through the addition of plasticizers.  The increased spherical nature 
would reduce surface area of the microcapsule thereby increasing stability of resveratrol.  
Therefore, the objective of this research was to evaluate the effect of plasticizers (propylene 
glycol, sorbitol, sucrose) on the UV stability of encapsulated resveratrol and morphology of the 
microcapsules.  It was found that the addition of plasticizers in the concentration range of 31.7-
47.6% (dry basis, w/w) to the resveratrol microcapsules decreased the trans:cis resveratrol ratio 
after UV light exposure, thereby indicating a decreased light stability in comparison to the 
formulation without added plasticizers.  The UV light stability of encapsulated resveratrol within 
a protein matrix with the inclusion of a plasticizer was not significantly different across the three 
plasticizer types.  Morphology images showed that the resveratrol microcapsules with sorbitol 
used as a plasticizer exhibited a more spherical shape.  The use of plasticizers also resulted in 
the microcapsule wall being thin and fragile which may be related to the decreased light stability 
of resveratrol in these microcapsules.  Since the addition of plasticizers did not increase stability 
of resveratrol nor enhance the spherical nature of the microcapsule, the secondary objective 
was to evaluate the effect of protein denaturation on UV stability of resveratrol within a 
microcapsule.  The exclusion of protein denaturation in the preparation of the resveratrol 
microcapsules resulted in a lower trans:cis resveratrol ratio after UV stability testing in 
comparison to microcapsules in which the preparation included protein denaturation.  The 
stability of resveratrol within microcapsules without protein denaturation was not significantly 
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different than that of microcapsules with added plasticizers.  Overall, the use of plasticizers and 
absence of protein denaturation in the processing of resveratrol microcapsules did not enhance 
the UV stability of the microcapsules.   
Keywords: plasticizers, microencapsulation, resveratrol, stability, morphology 
4.2 Introduction 
 Resveratrol (3,4’,5-trihydroxystilbene) is a polyphenol found in red grapes, red wine, 
peanuts and blueberries [1-4].  This compound has been associated with health benefits related 
to the prevention and alleviation of disease states related to cancer, diabetes, and heart disease 
[5-8].  Some of the challenges with resveratrol incorporation into food systems are bitterness 
and light instability [9-11].  Wines fortified with 20 and 200 mg resveratrol/L were found to have 
an increased bitterness in comparison to wines without fortification [9].  In terms of light 
instability, exposure of resveratrol to UV light for 1-2 hours isomerized 80-90% of resveratrol 
from the bioactive form to the bio-inactive form [10, 11].  The incorporation of resveratrol into a 
microcapsule with a stable wall material can help to overcome these challenges through the 
innovative processing of resveratrol utilizing spray drying.  Microencapsulation is readily used in 
the food industry to protect micronutrients and also enable the delayed release of flavor 
compounds [12, 13]. 
Our prior investigation was focused on the stability of resveratrol encapsulated in a 
sodium caseinate matrix (Chapter 3).  Encapsulation was able to increase both UV light and in-
vitro digestion stability of resveratrol.  Scanning electron microscope images showed that the 
resveratrol microcapsules were non-spherical and contained many folds and crevices.  It was 
hypothesized that the inclusion of plasticizers may further increase stability of the resveratrol by 
enhancing the spherical shape of microcapsules thereby decreasing the surface area of the 
compound that is exposed to environmental conditions.   
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The effect of plasticizers has been previously investigated in hydroxypropyl 
methylcellulose (HPMC) based microcapsules produced through spray drying [14].  Plasticizers 
that were used in the HPMC microcapsules were triethylcitrate, propylene glycol, polyethylene 
glycol, glycerin and citric acid.  Cohesiveness of the microcapsules was increased with the use 
of plasticizers.  Triethylcitrate microcapsule had a rapid release of the core material due to the 
porous nature of the microcapsules.  Propylene glycol, glycerin, and citric acid were shown to 
have positive effects on microcapsule wall formation and drug release kinetics.  Citric acid has 
also been used as a plasticizer in theophylline particles with a cellulose polymer [15].  The 
plasticizer addition increased the spherical nature of the particle and also the size of the drug 
crystals.   
There is a wide range of research that looked into the effect of plasticizers on film 
formation that potentially can be translated to microcapsule formation.  Sorbitol has been added 
to sodium caseinate films in ratios of plasticizer to sodium caseinate ranging from 1:65 to 2:1 
[16].  Partial specific volume of the sodium caseinate solution was reduced with the inclusion of 
sorbitol, which indicated a more ordered structure of the protein.  In addition, sorbitol led to a 
decrease in glass transition temperature.  The effect of plasticizers (sorbitol, glycerol, 
polyethylene glycol) was investigated in fish protein films [17].  The use of sorbitol increased 
mechanical resistance and decreased film flexibility.  In comparison, glycerol and polyethylene 
glycol exhibited a lower mechanical resistance and higher film flexibility.   Sucrose had a more 
significant effect as a plasticizer on elongation at break than invert sugar in cassava starch films 
[18].  In β-lactoglobulin films, the effect of glycerol, sorbitol, polyethylene glycol, and sucrose 
were compared according to the elastic modulus, tensile strength, and elongation percentage 
[19].   The plasticizer efficiency in the films was ranked from most to least efficient as glycerol, 
polyethylene glycol, sorbitol, and sucrose.          
 The objective of this study was to evaluate the effect of plasticizers on the stability of 
resveratrol in sodium-caseinate-based microcapsules and the morphology of the microcapsules.  
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The three plasticizers that were compared in terms of UV stability and morphology were 
propylene glycol, sorbitol, and sucrose.  The hypothesis was that plasticizers will help to 
enhance the spherical shape of the resveratrol microcapsules that would in turn increase the UV 
stability of resveratrol within the microcapsule.  The secondary objective was to evaluate the 
effect of protein denaturation in the microcapsule processing on the UV stability of resveratrol in 
microcapsules.  The hypothesis was that protein denaturation would enhance UV stability of 
resveratrol in the microcapsule by resulting in a more open protein structure thereby providing 
more access to resveratrol binding sites. 
4.3 Material and Methods 
4.3.1 Materials 
 Propylene glycol (USP) had a purity of 99.8%, and sorbitol was a 70% solution 
(USP/FCC); both were donated by Archer Daniels Midland (Chicago, IL, U.S.A.).  Sucrose used 
as a plasticizer was from C&H (Crockett, CA, U.S.A.).  Sodium caseinate was donated by 
Agropur (La Crosse, WI, U.S.A.), and resveratrol was donated by Dutch State Mines (DSM, 
Parsippany, NJ, U.S.A.).  All solvents used were HPLC grade and purchased from Sigma-
Aldrich (St. Louis, MO, U.S.A.).  The internal standard used was oxy-resveratrol with >98% 
purity from Cayman Chemicals (Ann Arbor, MI, U.S.A.).  Filters, used before HPLC analysis, 
were 0.2 uM PTFE (VWR, Radnor, PA, U.S.A.).  
4.3.2 Microcapsule Production 
 The formulations of resveratrol microcapsules are shown in Table 4.1.  All formulations 
were spray dried in duplicates.  Sodium caseinate solution was partially denatured for 2 hr in a 
shaking water bath (C76 Water Bath Shaker, New Brunswick Scientific, Edison, NJ, U.S.A.) at 
100 rpm and 80°C.  Plasticizers were added to the microcapsules in a 1:1 ratio of protein to 
plasticizer.  This level of plasticizer was chosen because it was the average of prior studies that 
used sorbitol and glycerol as plasticizers [16, 20].  Resveratrol and plasticizer were mixed into 
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the protein solution at 15,200 rpm with a hand mixer (IKA Works, Wilmington, NC, U.S.A.).  The 
resulting solution underwent 2 cycles of high-pressure homogenization (APV Gaulin Inc., 
Wilmington, MA, U.S.A.) at 55 MPa in order to create a homogeneous dispersion.  A lab-bench 
spray drier (B-290 Buchi Corporation, New Castle, DE, U.S.A.) was then used to produce 
resveratrol microcapsules with an inlet temperature of 160°C and outlet temperature of 90°C.   
Additional parameters of spray drying were flow rate between 5-7 g/min, air pressure of 5 kPa 
and nozzle diameter of 0.7 mm.  Aluminum foil was used to protect sample solutions from light 
exposure during the microcapsule production process.   
 SC-SOR microcapsules with a 2:1 ratio of sodium caseinate to sorbitol was spray dried 
with the same methodology as previously explained in this section.  The purpose was to test if 
the ratio of protein to plasticizer had a significant effect on resveratrol stability within the sodium-
caseinate-based microcapsule.  In addition, SC microcapsules without protein denaturation 
were also spray dried in order to observe the effect of protein denaturation on UV stability of 
resveratrol within the microcapsule.   
4.3.3 Morphology and Particle Size 
Scanning electron microscope (XL30 ESEM-FEG, FEI Company, Hillsboro, OR, U.S.A.) 
at Beckmann Institute for Advanced Science and Technology (Urbana, IL, U.S.A.) was used to 
observe the morphology of resveratrol microcapsules.  In order to prevent surface charging, 
gold-palladium through sputter coating (Desk-1 TSC, Denton Vacuum, Moorestown, NJ, U.S.A.) 
was used to coat samples before viewing with a scanning electron microscope.  Hivac mode 
was used to observe the morphology of the resveratrol microcapsules at a voltage of 5 kV.  
Particle size was estimated from the scanning electron microscope images.   
4.3.4 Moisture Content and Water Activity  
 Moisture content and water activity were measured in three replications with HR 83 
Halogen Moisture Analyzer (Mettler Toledo, Columbus, OH, U.S.A.) and Aqua Lab 4TE (Aqua 
Lab Technologies, Riverside, CA, U.S.A.), respectively.   
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4.3.5 HPLC 
 Resveratrol isomers were quantified on high-performance liquid chromatography using 
coulometric detection (ESA CoulArray detector, ThermoScientific, Sunnyvalle, CA, U.S.A.) and 
a C18 column (Phenomenex Gemini 5u, 110A, 150x4.6 mm, Torrance, CA, U.S.A.).  Standards 
of both resveratrol isomers and oxy-resveratrol (Cayman Chemicals, Ann Arbor, MI) were used 
to construct external standard curves.  The HPLC method utilized a gradient of two mobile 
phases, 100% methanol (Sigma-Aldrich, St. Louis, MO) and 25 mM sodium acetate (Sigma-
Aldrich, St. Louis, MO), pH 4.5.  The starting condition was 30% methanol which was held for 2 
min and gradually increased to 60% methanol at 14 min.  These conditions were held for 3 min, 
and the amount of methanol was decreased back to 30% within 2 min and held for an additional 
2 min.   
4.3.6 UV Stability 
 Ten mg of resveratrol microcapsules was added to 4 mL ultra-filtered water, to form a 
solution, in 15 mL centrifuge tubes (Thermo-Scientific, Rochester, NY, U.S.A.).  Samples were 
exposed to 365 nm of UVA light for 1 hr in Benchtop 2UV Transilluminator (LM-20E, Ultra-Violet 
Products Ltd., Upland, CA, U.S.A.).  Resveratrol was extracted from the microcapsules with 
probe sonication (Qsonica probe sonicator, Cole Palmer, Vernon Hills, IL, U.S.A.), using 3 
cycles of 30 sec continuous sonication then 30 sec no sonication.  The amplitude used in the 
sonication was 50%, and the diameter of the probe was 3.22 mm.  Sample tubes were placed in 
ice water during probe sonication in order to minimize heat buildup within the samples.  
Samples were filtered and then injected to HPLC to quantify resveratrol isomers.  The ratio of 
trans:cis resveratrol was compared among microcapsule formulations to evaluate UV stability of 
the encapsulated resveratrol.  UV stability testing was conducted in triplicates for each spray 
dried replicate.     
83 
 
4.3.7 Statistics 
 Statistical analysis system (SAS, Cary, NC, U.S.A.) was used to conduct analysis of 
variance (ANOVA) and least significant difference testing (LSD) on the data.  Microsoft Excel 
(Microsoft, Redmond, WA) was used to calculate the trans:cis resveratrol ratio of samples after 
UV light exposure.   
4.4 Results and Discussion 
4.4.1 Morphology and Particle Size 
 Scanning electron microscope images of resveratrol microcapsules are shown in Figure 
4.1.  Particle size for resveratrol microcapsules with sorbitol or sucrose used as a plasticizer 
ranged between 1-30 µm.  Resveratrol microcapsules with propylene glycol as a plasticizer 
ranged between 1-20 µm.  Sorbitol, as a plasticizer, helped to improve the spherical shape of 
the microcapsules in comparison to the formulation without the addition of plasticizer.  Sucrose 
and propylene glycol had a minimal effect on the microcapsule morphology.  Microcapsule walls 
appeared to be thin and fragile, according to the microscopic images at 10,000-20,000 
magnification (Figure 4.2).  In films, the addition of plasticizers has been shown to increase 
tensile strength that can decrease flexibility of the film thereby resulting in a brittle film [21].  
Propylene glycol as a plasticizer in β-lactoglobulin films resulted in a brittle film and the 
concentration of plasticizer was independent of mechanical strength [19].  Therefore, it is 
hypothesized that the addition of plasticizers in the resveratrol microcapsules caused the 
capsule wall to be weak and easily broken.  The wall flexibility was probably decreased and 
tensile strength increased, resulting in a capsule that was more rigid and broken with moderate 
force.  The walls may have been easily broken in the spray drying process as the particle 
expands and contracts onto itself due to the heat used in the drying process.     
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4.4.2 Moisture Content and Water Activity 
 Resveratrol microcapsules with propylene glycol as a plasticizer had a significantly 
higher moisture content than the sodium-caseinate-based resveratrol microcapsules without any 
added plasticizers (Table 4.2).  The resveratrol microcapsules with added propylene glycol also 
had the highest water activity out of all microcapsule samples.  Propylene glycol has a lower 
molecular weight than the other two plasticizers used in resveratrol microcapsules (sorbitol and 
sucrose).  Therefore, there were a larger number of propylene glycol molecules in the 
microcapsules than the other plasticizers, thereby providing more opportunity for the plasticizer 
to bind with the protein.  This decreased water binding with the protein may have resulted in a 
higher moisture content and water activity of the microcapsule.   
In addition, the use of sorbitol in the resveratrol microcapsules in a 2:1 ratio of sodium 
caseinate to plasticizer resulted in significantly lower moisture content than the sodium-
caseinate-based resveratrol microcapsules.  The addition of glycerol in chitosan films has been 
shown to have an increased moisture content with increasing concentration of the plasticizer, 
which disagrees with the findings of our study [22].  This occurrence indicated that the use of 
plasticizers can alter the moisture content and water activity of the matrix.  Water sorption in 
films has been shown to be affected by a range of factors including size of the plasticizer, 
interaction between water molecules, plasticizers and polymers [23].  Some plasticizers may 
increase the water activity or moisture content while other plasticizers may decrease these 
measurements.    
4.4.3 UV Stability 
 The trans:cis resveratrol ratios of microcapsules with added plasticizers after UV light 
exposure was significantly lower than microcapsules without plasticizers and unencapsulated 
resveratrol (Figure 4.3).  Therefore, the addition of plasticizers to resveratrol microcapsules 
decreased the trans:cis resveratrol ratio after UV exposure.  The effect of plasticizers in tara 
gum films have been studied, and it was found that the plasticizers increased mobility of the 
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polymers within the film by decreasing intermolecular forces [24].  These results suggest that 
the addition of plasticizers in the resveratrol microcapsules caused an increased mobility of 
molecules that in turn may result in a higher concentration of resveratrol migrating to the surface 
of the microcapsule.   
It has been found that the size, shape and composition of a plasticizer can affect the 
ability of a protein film from forming hydrogen bonding [19].  Therefore, incorporation of 
plasticizers into the resveratrol microcapsules may have affected the stability of the compound 
as the plasticizer binds with the protein, thereby reducing the number of binding sites available 
to resveratrol.   
 There was no significant difference between the type of plasticizer used in the 
microcapsule in terms of UV stability of resveratrol.  Sorbitol and sucrose have been previously 
compared as plasticizers in protein films, and it was found that sorbitol was a more effective 
plasticizer in terms of elasticity, tensile strength and elongation [19].  In our research, the 
plasticizers were compared only on the basis of UV stability that is aligned with evaluating the 
light stability of resveratrol.  The parameters measured in the protein films with added 
plasticizers may not be directly correlated to UV stability of resveratrol in protein-based 
microcapsules.   
When the amount of sorbitol in the microcapsule was decreased to a 2:1 ratio of protein 
to plasticizer, the trans:cis resveratrol ratio did not change significantly from microcapsules with 
a 1:1 ratio of protein to plasticizer (Figure 4.3).  The ratio of sodium caseinate to sorbitol did not 
significantly affect the UV stability of resveratrol within the microcapsules.  In addition, the lack 
of denaturation of sodium caseinate significantly decreased the trans:cis resveratrol ratio after 
UV exposure in comparison to the sodium-caseinate-based microcapsule with protein 
denaturation.  Therefore, protein denaturation plays a significant role in enhancing UV stability 
of resveratrol within a protein microcapsule.  Denaturation of protein has been defined as “a 
major change from the original native structure, without alteration of the amino acid sequence” 
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[25].  Thus, the change in the native structure of sodium caseinate resulted in an increased UV 
stability, perhaps by increasing the number of binding sites available on the protein for 
resveratrol to bind.   
4.5 Conclusions 
 Plasticizers have been shown to increase tensile strength of protein gels but when they 
were applied to microcapsules with the objective of protecting resveratrol, they were not able to 
increase stability of the compound.  Tensile strength and other parameters commonly measured 
in films may not be directly related to enhanced stability of bioactive compounds in microcapsule 
matrixes.  The use of stability testing is the most direct means to evaluate the effect of additional 
components in microcapsules.  Moisture content and water activity are thought to be factors that 
affect the stability of these bioactive compounds, due to their effect on mobility of the compound 
within the matrix.  A limitation of this study was the effect of plasticizers was only investigated in 
sodium-caseinate-based microcapsules.  In order to protect resveratrol from environmental 
factors, the incorporation of plasticizers into other types of protein-based microcapsules can be 
further investigated in the future.  Another limitation of this research was the morphology of the 
microcapsules were only qualitatively evaluated by scanning electron microscope imaging and 
future research can evaluate morphology through a quantitative measure.  In addition, it is 
important to note that the morphology of the particles may be different with scale up using a 
larger spray dryer.   
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4.6 Figures and Tables 
Figure 4.1: Scanning electron microscope images of sodium-caseinate-based resveratrol 
microcapsules with and without plasticizers 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SC: sodium caseinate without plasticizer 
SC-PG: sodium caseinate with propylene glycol 
SC-Sor: sodium caseinate with sorbitol 
SC-Suc: sodium caseinate with sucrose 
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Figure 4.2: Scanning electron microscope at 10,000x and 20,000x magnification of 
resveratrol microcapsules with added plasticizers 
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Figure 4.3: Trans:Cis resveratrol ratio of resveratrol microcapsules with and without 
plasticizers in comparison to unencapsulated resveratrol (Resv) 
  
SC-PG: sodium caseinate with propylene glycol (1 protein:1 plasticizer) 
SC-Suc: sodium caseinate with sucrose (1 protein:1 plasticizer) 
SC-Sor: sodium caseinate with sorbitol (1 protein:1 plasticizer) 
SC-Sor 2:1: sodium caseinate with sorbitol (2 protein:1 plasticizer) 
SC Undenaturated: sodium caseinate without plasticizer, protein undenatured 
SC: sodium caseinate without plasticizer 
R: replication 
Resv: unencapsulated resveratrol 
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Table 4.1: Resveratrol microcapsule formulations with the addition of plasticizers and the 
sodium-caseinate-based microcapsule without plasticizer (SC) 
Component SC SC-PG SC-Sor SC-Suc 
Sodium Caseinate 80 g 80 g 80 g 80 g 
Plasticizer Purity --- 99.8% 70% ~100% 
Plasticizer Amount --- 80 g 114 g 80 g 
Deionized Water 920 g 920 g 886 g 920 g 
Trans-Resveratrol 
(% by total solids) 
4 g (4.8%) 8 g (4.8%) 8 g (4.8%) 8 g (4.8%) 
 
SC: sodium caseinate without plasticizer 
SC-PG: sodium caseinate with propylene glycol 
SC-Sor: sodium caseinate with sorbitol 
SC-Suc: sodium caseinate with sucrose 
Sorbitol was a 70% solution with the remaining 30% being water.  The purity of this plasticizer 
was accounted for in the microcapsule formulations.   
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Table 4.2: Resveratrol microcapsule analyses of mean moisture content (%) and mean 
water activity of resveratrol microcapsules with the addition of plasticizers, sodium-
caseinate-based microcapsule without protein denaturation (SC-Undenat) and sodium-
caseinate-based microcapsule without plasticizer (SC) 
 
Moisture Content Water Activity 
SC-PG R1 3.14a 0.33a 
SC-PG R2 2.87ab 0.27b 
SC-Sor R1 1.67abc 0.08g 
SC-Sor R2 2.81efg 0.18c 
SC-Suc R1 1.88ef 0.10e 
SC-Suc R2 1.70efg 0.06i 
SC-Sor2:1 R1 1.61fg 0.08f 
SC-Sor2:1 R2 1.34g 0.07g 
SC-Undenat R1 2.53bcd 0.07h 
SC-Undenat R2 2.41bcd 0.05j 
SC R1 2.12de 0.07h 
SC R2 2.35cd 0.11d 
 
R = replication 
SC-PG: sodium caseinate with propylene glycol 
SC-Sor: sodium caseinate with sorbitol 
SC-Suc: sodium caseinate with sucrose 
SC-Sor 2:1: sodium caseinate with sorbitol (2 protein:1 plasticizer) 
SC-Undenat: sodium caseinate with plasticizer, protein not denatured 
SC: sodium caseinate without plasticizer 
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CHAPTER 5: TASTE DETECTION THRESHOLDS OF RESVERATROL  
5.1 Abstract 
 Resveratrol is a polyphenol that is associated with numerous health benefits related to 
heart disease, cancer, diabetes and neurological function.  The addition of this compound to 
food products would help to deliver these health benefits to the consumer.  However, bitterness 
associated with resveratrol may impart negative sensory qualities on the food products, which 
may decrease consumer acceptability.  This concern may be resolved by encapsulating 
resveratrol through spray drying, an innovative processing technique.  The objectives of this 
research were to: 1) compare taste detection thresholds of unencapsulated resveratrol 
(unencapsulated) and encapsulated resveratrol and 2) determine if the inclusion of anhydrous 
milk fat in the formulation affects the taste detection threshold of resveratrol within the 
microcapsules.  Resveratrol microcapsules were produced by encapsulating resveratrol in a 
protein matrix through spray drying.  R-index measure by the rating method was used to find the 
average taste detection threshold and the pooled group taste detection threshold.  The average 
and pooled group taste detection thresholds for resveratrol, sodium-caseinate-based resveratrol 
microcapsule without fat (SC), and sodium-caseinate-based resveratrol microcapsule with fat 
(SCAMF) were: 90 and 47 mg resveratrol/L, 313 and 103 mg resveratrol/L, 334 and 108 mg 
resveratrol/L of resveratrol, respectively.  The findings demonstrate that the encapsulation of 
resveratrol decreased the detection of the compound and provided a means to incorporate the 
resveratrol into food products without imparting negative sensory properties.  
Keywords: Resveratrol, threshold, encapsulation, R-index, bitterness 
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5.2 Introduction 
 Resveratrol is one of the polyphenols found in the skin of red grapes and red wine, 
which contributes to the health benefits of red wine [1, 2].  It has been shown to have positive 
impacts on heart disease, cancer, diabetes and neurological function [3-6].  The addition of 
resveratrol to food products would help to offer biologically active concentrations of the 
compound in easy-to-consume foods in order to provide the health benefits to the consumer.   
One of the challenges with the incorporation of resveratrol into products is the astringent 
and bitter perception of the compound being a polyphenol [7].  However, there has been limited 
research related to the sensory perception of resveratrol.  Descriptive analysis testing was 
utilized to evaluate bitterness of Riesling wine fortified with resveratrol [7].  A significant 
difference in bitterness existed between wines fortified with resveratrol at 20 mg/L and the 
control without any resveratrol.  Significant differences in bitterness also existed between wines 
fortified with 20 and 200 mg resveratrol/L, with the higher concentration being rated as more 
bitter.   
Chemical analysis on 23 Italian wines showed the concentration of resveratrol in wine 
ranged from 0.18-5.44 mg resveratrol/L with the exception of one wine that had no resveratrol 
content  [8].  For the sensory evaluation of the Italian wines, a trained panel rated samples 
according to a criteria commonly used for wine judging competitions according to the 
Associazione Enotecnici Italiani-Organizzazione Nazionale Assagiatori Vini model which 
provided one sensory evaluation score that took into account all categories such as 
appearance, taste and bouquet.  There was no direct correlation between the overall sensory 
ratings and the resveratrol content.  Overall sensory ratings were the only form of sensory 
evaluation conducted and specific attributes were not evaluated individually.   
 There is very limited prior research on the sensory properties of resveratrol and none 
that investigated the taste detection threshold of this compound.  In addition, no research has 
explored encapsulation of resveratrol as a way to mask the unattractive sensory perception of 
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resveratrol, which, in turn, could maintain consumer acceptance of products with added 
resveratrol.  In this research study, signal detection rating method was used to measure taste 
threshold values of unencapsulated resveratrol and encapsulated resveratrol in solution.  The 
first objective of this research was to compare the taste detection threshold of resveratrol 
microcapsules with a protein matrix to that of unencapsulated resveratrol.  The hypothesis was 
that the resveratrol within the microcapsules would have a higher taste detection threshold than 
unencapsulated resveratrol.  The second objective was to determine the effect of anhydrous 
milk fat in the microcapsule formulation on taste detection threshold of resveratrol within the 
microcapsule.  Due to the higher fat solubility of resveratrol, the hypothesis was that the 
resveratrol would be dispersed within the fat and the protein would form a protective layer 
around the fat.  Therefore, the taste detection threshold of resveratrol when encapsulated with 
fat and protein combined was hypothesized to be higher than that of resveratrol microcapsules 
that only utilized protein as a matrix.  This research can provide an indication of the ideal level at 
which encapsulated resveratrol microcapsules can be added to food products without a 
negative impact on sensory properties of the product.   
5.3 Materials and Methods 
5.3.1 Encapsulated Resveratrol Production 
Taste detection threshold was evaluated for two formulations of encapsulated 
resveratrol.  The first formulation contained 95.2% sodium caseinate (Agropur Ingredients, La 
Crosse, WI, U.S.A.) and 4.8% resveratrol (DSM, Parsippany, NJ, U.S.A.) by solid weight basis.  
The second formulation contained 52.9% anhydrous milk fat (Danish Maid, Chicago, IL, U.S.A.), 
42.3% sodium caseinate and 4.8% resveratrol, by solid weight basis. The amount of protein in 
the sample solution (8%) before spray drying was determined from prior research in our lab to 
be a level at which the protein could be solubilized in solution [9].  The amount of anhydrous 
milk was slightly higher than the amount of protein in the formulations.  The increased amount of 
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fat was used to help solubilize the resveratrol within the solution [10].  Resveratrol concentration 
was kept consistent among formulations at 4.8% resveratrol (dry basis, w/w).  This resveratrol 
concentration was chosen to provide more wall material than resveratrol. 
Two formulations of resveratrol microcapsules were tested in order to compare the effect 
of anhydrous milk fat in the microcapsule formulation on the taste detection threshold of 
resveratrol.  Sodium caseinate was partially denatured for 2 hours at 80ºC and 100 rpm in a 
shaking water bath (C76 Water Bath Shaker, New Brunswick Scientific, Edison, NJ, U.S.A.).  
Anhydrous milk fat and resveratrol were mixed into the protein solution using a hand mixer (IKA 
Works, Wilmington, NC, U.S.A.) at 15,200 rpm for 3 min.  An evenly dispersed solution was 
obtained through a two-stage high-pressure homogenization (APV Gaulin Inc., Wilmington, MA, 
U.S.A.) at 55 MPa.  Resveratrol microcapsules were produced through spray drying with Buchi 
B-290 (New Castle, DE, U.S.A.) spray dryer.  The following spray drying conditions were used: 
160ºC inlet temperature, 90ºC outlet temperature, 0.7 mm nozzle diameter, 4.5-7.5 g/min flow 
rate and 7 kPa. 
5.3.2 Sample Preparation 
Unencapsulated resveratrol and the two types of encapsulated resveratrol were tested at 
five concentrations, in three-fold increments.  The concentrations of unencapsulated resveratrol 
tested were 2.2, 6.7, 20, 60, and 180 mg resveratrol/L.   The water solubility of resveratrol is 
0.03 mg/mL; therefore, it is assumed that 30 mg/L of resveratrol is soluble and the remaining 
resveratrol concentration is dispersed in solution [11].  The concentrations of resveratrol in the 
microcapsules tested were 4.4, 13.3, 40, 120, and 360 mg resveratrol/L.  These levels were 
established by 2 rounds of preliminary testing with individuals who were familiar with threshold 
testing.  The first round of preliminary testing used 12 panelists (4 males and 8 females) and 1 
replication of each concentration/panelist was tested.  The concentrations tested for 
unencapsulated resveratrol were 0.625, 1.25, 2.5 and 40 mg resveratrol/L.  The concentrations 
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tested for encapsulated resveratrol were 0.625, 1.25, 2.5 and 80 mg resveratrol/L.  The rinse 
protocol consisted of 1) warm water and 2) room temperature water.   
The second round of preliminary testing used 13 panelists (5 males and 8 females) and 
two replications of each concentration/panelist were tested. The concentration tested for 
unencapsulated resveratrol was 20 mg resveratrol/L and for encapsulated resveratrol was 40 
mg resveratrol/L.  The rinse protocol consisted of 1) room temperature water (Absopure, 
Urbana, IL, U.S.A), 2) ice cream (Meijers, Grand Rapids, MI, U.S.A.), 3) carbonated water 
(Meijers, Grand Rapids, MI, U.S.A.) and 4) room temperature water (Absopure, Urbana, IL, 
U.S.A).  The inclusion of the ice cream and carbonated water in the rinse protocol helped to 
further cleanse the palette in comparison to the first testing.   
In both preliminary tests, testing was conducted under incandescent lighting in a 
conference room and responses were collected on paper ballots.  The noise sample was 0.4% 
ethanol solution for unencapsulated resveratrol and spring water for the resveratrol 
microcapsules.  The signal sample was the highest concentration of resveratrol being tested.  
Panelists were first asked to familiarize themselves with both the signal and noise samples.  
Once familiar with these samples, they were presented with the test samples and rated each 
sample according to four options: 1) Signal Sure, 2) Signal Unsure, 3) Noise Unsure, and 4) 
Noise Sure.   
For the actual testing, six replications of the noise and each concentration were tested.  
The noise sample was the background solution which unencapsulated resveratrol or the 
microcapsules were dispersed within.  In order to solubilize resveratrol, it was dissolved in 1.2% 
ethanol (EtOH), 190 Proof, USP (New Brunswick, NJ, U.S.A.).  It was confirmed by HPLC that 
1.2% EtOH (v/v) was sufficient to dissolve 180 mg resveratrol/L (Appendix A).  The 
encapsulation of resveratrol helped to increase its solubility; therefore, it was not necessary to 
use an ethanol solution for these samples.  Resveratrol microcapsules without anhydrous milk 
in the formulation were added to a base protein solution.  The sodium caseinate added to the 
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base solution differed for each microcapsule concentration in order for the sum of protein in the 
microcapsules and in the base solution to be equal to that in the highest concentration of 
microcapsules.  A similar procedure was applied to microcapsules with the inclusion of 
anhydrous milk fat, the difference being that the base solution included both anhydrous milk fat 
and protein, in order to keep the amount of protein and fat consistent across all microcapsule 
concentrations.   All base solutions underwent two-stage high-pressure homogenization (APV 
Gaulin Inc., Wilmington, MA, U.S.A.) at 55 MPa in order to keep the solutions homogeneous.   
 All samples were prepared the day before testing, in a room without windows and under 
amber light, in order to minimize light degradation of resveratrol.  The wavelength associated 
with yellow or amber light is the least degradative to light-sensitive resveratrol [12].  Twenty mL 
of sample was placed in 60 mL clear, plastics containers with lids.  Samples were put on trays, 
and the entire tray was covered with foil and stored between 3-5°C, overnight.  Samples were 
labeled with a 3-digit code and served at room temperature.  
5.3.3 Rating Method and R-index Measurement 
R-index by rating method and the American Society of Testing and Materials (ASTM) 
method of ascending limits are the most commonly used threshold methods [13-18].  R-index 
measurement by rating has been used in relation to the noise and signal samples [19].  R-index 
by rating method and ASTM method have been found to be similar when the thresholds of 
caffeine solutions determined by the two methods were compared [13]. R-index by rating 
method was proposed to be a more efficient method than ASTM, because fewer samples were 
needed [13, 20].   
5.3.4 Taste Detection Threshold Testing 
This study utilized 33 panelists between 18-45 years of age, 11 males and 22 females.  
Panelists were asked to not eat, drink, or smoke at least 30 minutes prior to the testing.  They 
were also instructed to not wear strong cosmetics that may interfere with their perception of the 
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samples.  In the first session, panelists received a brief presentation on the testing method in 
order to familiarize them with the rating method used to determine the R-index measure.    
The testing was completed in a booth setting with red lighting, positive air flow, and room 
temperature of 25ºC.  Sample cups were placed on top of red colored paper on trays to help 
mask color differences across the samples.  Compusense® five Plus (version 5.6, Guelph ON, 
Canada) was used to determine a randomized complete block design for six replications of five 
concentration levels and the noise.  Each panelist rated six replications of each concentration of 
unencapsulated resveratrol and encapsulated resveratrol.     
The taste detection threshold testing began with a warm-up phase, in which panelists 
were presented with two samples: Noise and Signal.  The noise sample was 1.2% ethanol for 
unencapsulated resveratrol samples.  For resveratrol microcapsules, the noise sample was the 
base solution to which the microcapsules were added, as described in the sample preparation 
section.  The signal sample was the highest concentration of the sample being tested in the test 
design.  Panelists were instructed to swirl the samples on the tray for 2-3 seconds, then, place 
the sample in their mouth and swish around for 2-3 seconds.  After waiting 10 seconds, the 
panelists were asked to focus on the perception of the sample, in order to fully assess 
astringency which can be a delayed perception.  Panelists rinsed their mouth with the same 
rinse protocol before and between all samples.  The rinse protocol was as follows: 1) heavy 
whipping cream (Land O'Lakes, Arden Hills, MN, U.S.A.), 2) carbonated water (Meijers, Grand 
Rapids, MI, U.S.A.), 3) room temperature water (Absopure, Urbana, IL, U.S.A).  All samples and 
rinses were expectorated.    
Once the panelists were familiar with the Noise and Signal samples, they were 
presented with the first sample tray which contained six samples (5 concentration levels of 
resveratrol and one noise sample).  The panelists rated all samples in comparison to the noise 
and signal samples, choosing one of the four options: Signal Sure, Signal Unsure, Noise 
Unsure, Noise Sure.  The testing protocol of the samples was similar to the warm-up phase, 
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where panelists were instructed to swirl the cup on the tray before tasting and a 10-second timer 
was embedded to the program to force panelists to wait 10-seconds before rating each sample.  
Panelists were allowed to re-taste the noise and signal samples at any time.  
After the completion of the first sample set, there was a 2-minute break, during which 
time the panelists held ¼ of a slice of Sara Lee Soft and Smooth bread with no crust (Chicago, 
IL, U.S.A.) in their mouth compressed between the top of the mouth and tongue to soak up any 
residue sample or rinses.  A built-in 2-minute timer in the Compusense® five Plus system 
(version 5.6, Guelph ON, Canada) reinforced the break.  After compressing the bread in the 
mouth, panelists repeated the rinse protocol to cleanse the palate. Then, the panelists rated 
another six samples that consisted of five concentration levels and the noise.    
5.3.5 Testing of Additional Concentration Level 
 The empirical threshold is defined as 50% above the chance probability of selecting the 
correct answer (R-index of 50%) [21], an R-index of 75% is the empirical threshold [13, 20, 22].  
A number of panelists (11 panelists for unencapsulated resveratrol, 16 panelists for SC, 20 
panelists for SCAMF) did not reach their individual threshold in the five concentration levels of 
unencapsulated resveratrol and encapsulated resveratrol testing.  The pooled R-index reached 
above 75% only for the resveratrol testing range. Therefore, an additional testing was 
completed, which included the highest concentration from the original testing, a concentration 
that was 3-fold higher than the highest level from the original testing, and the noise to more 
accurately determine the pooled and individual threshold values.  Resveratrol was dissolved in 
3.6% ethanol.  Ethanol content was increased 3-fold from the original testing because the 
concentration of resveratrol was tripled.   
The additional testing was conducted in a similar manner to the original testing, but 
panelists evaluated a total of 15 samples per session.  Sample order was randomized using 
Compusense® five Plus (version 5.6, Guelph ON, Canada) program, between and across all 
sample sets.  Five replications of each sample were tested with three sample trays of five 
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samples per tray.  The same warm-up and rinse protocol were used in the additional testing.  
Five samples were served on each tray with a 2-minute break between each sample tray, in 
which panelists held ¼ of a slice of bread compressed between the tongue and top of the 
mouth.  After the 2-min break, panelists rinsed their mouth with the established protocol.   
5.3.6 Post-Questionnaire 
At the completion of the threshold testing, all panelists filled out a questionnaire that was 
aimed at gathering 1) demographic information, 2) information on a suitable product for a health 
claim related to resveratrol, and 3) knowledge of resveratrol.  Some of the questions included: 
"What product would be best aligned with the health claim, may decrease cancer risk, increase 
heart health and neurological function?" and "Which of the following health benefits do you 
associate with resveratrol?”   Responses were collected on paper ballots, shown in Appendix B.  
5.3.7 Data Statistical Analysis 
 Data were collected using Compusense® five Plus (version 5.6, Guelph ON, Canada).    
This software assigned randomized sample orders to each panelist and presented the testing 
questions along with the embedded timer to panelists throughout the testing.  Data were 
exported into Microsoft Excel (Microsoft, Redmond, WA, U.S.A.).  Statistical Analysis System 
(SAS, Cary, NC, U.S.A) was used to conduct analysis of variance (ANOVA) and least significant 
difference (LSD) test on the data.  Nonparametric LSD was used to find where the difference 
existed between check-all-that-apply questions in the post questionnaire related to health 
benefits of resveratrol.   
5.3.8 Taste Detection Threshold Calculations 
Taste detection thresholds were calculated for all pooled data and each panelist using 
the R-index response matrix method [22].  For each panelist, resveratrol concentration (x-axis) 
was plotted against the R-index percentage (y-axis).  A linear line was constructed between the 
two points above and below an R-index of 75%.  Then, this linear equation was used to 
calculate the resveratrol concentration (x-axis) at which the R-index (y-axis) was 75%.  The R-
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index of panelists who participated in the additional testing was calculated by the additional 
testing data of the 180 mg resveratrol/L and 540 mg resveratrol/L in the microcapsules.  
Panelists who did not have a taste detection threshold within the concentration range tested in 
both the original and additional testing were not included in the average or pooled threshold 
calculations.  The sample size (N) in Table 5.1 indicates the number of panelists who had a 
taste detection threshold within the tested concentration range.  Pooled taste detection 
thresholds (mg/L) were calculated by compiling the individual data from all panelists who 
reached threshold in the first testing and data from the second testing of those who reached 
threshold during the additional testing.  The sample size for the pooled threshold was 198 (6 
replications of each sample per panelist with a total of 33 panelists).   
5.4 Results and Discussion 
5.4.1 Taste Detection Threshold 
 The average individual panelist thresholds for encapsulated resveratrol were significantly 
higher than unencapsulated resveratrol (Table 5.1).  This indicated that the unencapsulated 
resveratrol was detected at a lower concentration than resveratrol in the microcapsules.   The 
findings demonstrated that encapsulation of resveratrol within a protein or protein and fat matrix 
successfully masked the detection of the compound in aqueous solutions.  The presence of fat 
within the formulation did not significantly decrease the detection of resveratrol as hypothesized, 
which was evidenced by no difference between the thresholds of SC and SCAMF formulations 
(P>0.05).  These results were contrary to our expectations.  The anhydrous milk fat is solid at 
room temperature, which is the temperature that samples were served.  Therefore, the 
resveratrol would be physically encapsulated within the fat of the microcapsules.  Opposed to 
the microcapsules without anhydrous milk fat, in which resveratrol could be more easily 
extracted from the microcapsules when in solution.  One possible explanation is that the 
resveratrol microcapsules were hollow as shown by scanning electron microscope images 
104 
 
(Chapter 3).  Therefore, the water can diffuse into the microcapsules when mixed into a 
solution.  In this way, the resveratrol may diffuse into the aqueous phase and reach equilibrium 
between the inside and outside of the microcapsule.   
 The pooled threshold of each sample was 2- to 3-fold lower than the average of the 
individual panelists’ threshold (Table 5.1).  In a past study on mouthfeel detection threshold for 
sucrose and high fructose corn syrup (HFCS), the average of individual panelist thresholds and 
pooled taste detection thresholds were similar to each other [14].  In comparison, the pooled 
threshold of sulfur compounds in wines was 2- to 3-fold higher than the average individual 
panelists’ threshold [23].   The discrepancy seen in our study between individual panelists’ 
average taste threshold and pooled threshold may have been due to the variation between the 
propylthiouracil (PROP) status of panelists [24, 25].  PROP tasters may have been able to 
detect the bitterness of resveratrol at a lower concentration than panelists who are not PROP 
tasters.  Therefore, the taste threshold of individuals who are PROP tasters would have a lower 
individual taste detection threshold than panelists who are non-PROP tasters.  The number of 
replications to calculate the pooled taste threshold was 198, while the number of replications for 
each sample for individual taste threshold was 6.  The difference in threshold levels may be 
attributed to the difference in the number of replications.  The larger sample size used for the 
pooled threshold may have minimized the variability across individual panelists [26].  Although 
the pooled and average of the individual thresholds were different, the encapsulated resveratrol 
had a higher threshold than the unencapsulated resveratrol in both the pooled and average 
threshold results.  Thereby, this supported that the effectiveness of the encapsulation of 
resveratrol to mask the detection of the compound. 
 The number of panelists who had a taste detection threshold in the original testing for 
unencapsulated resveratrol, SC, and SCAMF was 22, 17, and 13, respectively.  These findings 
suggested that as the complexity of the sample increased, the ability for the panelists to detect 
the compound decreased.  SCAMF had the most complex sample matrix with the inclusion of 
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resveratrol within sodium caseinate and anhydrous milk fat.  It was assumed that the sodium 
caseinate and milk fat contributed to the flavor notes of the samples that may have helped to 
mask the bitterness or astringency of resveratrol.  These results were in line with previous 
research that compared the thresholds of pure limonin and naringin in different matrices which 
included distilled water, sucrose solutions, citric acid solutions and citrus juice model systems 
[27].  Limonin and naringin in a juice model system increased the threshold several folds in 
comparison to the compounds in distilled water.  Another study investigated the recognition 
threshold of limonin and naringin in orange juice and found that the addition of sucrose to the 
matrix decreased the bitterness of the compounds [28].  Therefore, an increased complexity of 
the sample matrix can increase taste detection threshold of a compound within that matrix. 
The increased threshold of resveratrol in the microcapsules also aligned with prior 
findings which showed that the addition of sodium caseinate can lower the bitterness of olive oil 
phenolics in an oil-free and 65% oil-in-water emulsion [29].  Our findings demonstrated that 
encapsulation with sodium caseinate can mask bitterness of polyphenols in aqueous solutions.    
Taste detection threshold testing using the R-index measure by rating method has been 
completed for isoflavonoids such as genistein and daidzein [30].  The respective taste detection 
thresholds for these compounds were 1080 mg/L and 740 mg/L.  In addition, caffeine taste 
detection thresholds have been found to be between 148-260 mg/L [13].  The taste detection 
thresholds of resveratrol was lower than genistein, daidzein, and caffeine indicating the 
importance of the use of innovative processing methods to decrease the detection of 
resveratrol.   
5.4.2 Post Questionnaire 
 Rank analysis in regards to the type of food product that would be best aligned with a 
health statement related to resveratrol found that there was a significant difference across the 
product choices.  Yogurt had a significantly higher preference rank than all other products, 
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followed by drink and snack bars, which were not significantly different from one another.  
Cookies had the lowest preference rank among all the food products. 
 When panelists were asked what health benefits they associated with resveratrol, “anti-
aging” was the most recognized (14 out of 33), followed by “prevent/treat cancer” (12 out of 33).  
The option of “lower blood sugar levels” was selected the fewest number of times (5 out of 33).  
“Anti-aging” was chosen significantly more than “lower blood sugar levels”, while the other 
options were not significantly different from one another.  The health benefits selected most 
often were different than those normally associated with wine, which may indicate that the 
panelists were not making a direct association between the health benefits of wine and 
resveratrol.  The findings suggested that panelists associated resveratrol as an anti-aging 
compound.   Thus, the ideal marketing of a product that contains resveratrol may need to 
include the health benefits of the compound in order to show consumers the range of health 
benefits associated with resveratrol.   
5.5 Conclusions 
 This research sheds light on the taste detection threshold of resveratrol and 
encapsulated resveratrol.  The encapsulation of resveratrol significantly increased the taste 
detection threshold of the compound in comparison to unencapsulated resveratrol, suggesting 
that microencapsulation successfully masked taste or other sensory characteristics of the 
compound.  Therefore, the encapsulation of resveratrol provides the food industry a means to 
add resveratrol into a wide range of foods products without negatively affecting sensory 
attributes of the product.  Use of spray drying as the processing method and sodium caseinate 
as an encapsulation matrix are good options to produce resveratrol microcapsules due to the 
wide availability and low cost of this method and ingredient.  
 One limitation of this study was that all samples were expectorated which is not a typical 
way consumers would consume food products.  The bitterness of resveratrol is often a delayed 
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perception which may be decreased when samples are not swallowed.  We decided to have 
panelists expectorate all samples in order to minimize fatigue and instead enforced a 10-second 
timer before samples were rated.  Yet, the results still demonstrated a significant difference 
between taste detection of unencapsulated resveratrol and encapsulated resveratrol.  Another 
limitation was that this research only focused on encapsulation of resveratrol with sodium 
caseinate as a wall material, and the findings from this study cannot be extrapolated to the taste 
detection threshold of resveratrol encapsulated within other wall materials.  Future research 
could investigate the taste detection threshold of resveratrol encapsulated within different types 
of encapsulation material such as cyclodextrins and gums.  In addition, descriptive analysis 
testing could be conducted in order to determine the specific sensory properties that may differ 
between resveratrol and encapsulated resveratrol in solution and food products.  This would 
help to gain a better understanding of the effects of resveratrol on sensory properties when 
added to food products. 
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5.6 Figures and Tables 
Figure 5.1: Distribution of individual panelists’ taste detection thresholds of 
unencapsulated resveratrol, resveratrol encapsulated in SC (sodium caseinate) matrix, 
and resveratrol encapsulated in SCAMF (sodium caseinate with anhydrous milk fat) 
matrix 
 
 
 
 
 
 
 
 
 
 
Total number of panelists who reached threshold was 27 for resveratrol, 26 for SC, and 22 for 
SCAMF. 
Resveratrol: unencapsulated resveratrol 
SC: sodium-caseinate-based microcapsule without anhydrous milk fat 
SCAMF: sodium-caseinate-based microcapsule with anhydrous milk fat 
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Figure 5.2: Check-all-that-apply results from health benefits associated with resveratrol 
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Table 5.1: Pooled threshold, average of individual panelist threshold, range of individual 
panelist thresholds and number of panelists who reached threshold in the concentration 
range tested (N), out of 33 total panelists in the taste detection threshold testing of 
resveratrol solutions 
 
   
Resveratrol SC SCAMF 
Pooled threshold 47 103 108 
Average Individual 
Panelist Threshold 
90A (±96) 313B (±286) 334B (±314) 
Range of Individual 
Panelist Threshold 
17-390 47-990 9.38-998 
N 27 26 22 
 
Threshold and range expressed in mg/L. 
Same letter superscripts for the average threshold represent not significantly different values 
(p<0.05). 
Resveratrol: unencapsulated resveratrol 
SC: sodium-caseinate-based microcapsule without anhydrous milk fat 
SCAMF: sodium-caseinate-based microcapsule with anhydrous milk fat 
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CHAPTER 6: CONSUMER ACCEPTANCE OF BARS AND GUMMIES WITH 
RESVERATROL AND ENCAPSULATED RESVERATROL 
6.1 Abstract 
 The addition of resveratrol, a polyphenol found in red wine and peanuts, to food products 
would help to provide the health benefits associated with the compound to the consumer in a 
wide array of food matrices.  The bitterness of resveratrol and instability in light are two major 
challenges with the incorporation of the compound into food products.  In this research, 
microencapsulation in a sodium caseinate matrix was utilized as a strategy to overcome these 
challenges.  The objective of this research was to show the application of the resveratrol 
microcapsules in easy-to-consume foods.  Consumer acceptance was evaluated for gummies 
and bars with encapsulated resveratrol in comparison to the controls.  Two concentrations of 
resveratrol that have been shown to have therapeutic effects in humans were tested (10 and 40 
mg/serving).  The overall liking of bars with 10 mg of encapsulated resveratrol did not differ 
significantly from the sample without any added resveratrol or protein or from bar samples with 
equivalent protein and/or resveratrol concentrations.  For gummies, the samples with the 
resveratrol microcapsules had a significantly lower overall liking than samples with the same 
protein and/or resveratrol content.  The differing results across bars and gummies suggest that 
a more complex matrix may help to mask the negative sensory properties of resveratrol.  A 
cluster of panelists was identified who preferred the bar samples with 10 mg encapsulated 
resveratrol (SC 10) more than bar samples with the same amount of protein and 
unencapsulated resveratrol (P+R 10) and the bar sample with the same protein concentration 
only (PRO 10).  The findings suggest that complexity of the food matrix may affect the masking 
of negative sensory properties of resveratrol.  Future research can identify which component of 
the matrix (ex. fat, sugar) has the most significant effect on masking these properties.    
Keywords: consumer testing, overall liking, CATA, resveratrol, microencapsulation         
114 
 
6.2 Introduction 
 Resveratrol is a polyphenol found in the skin of red grapes, red wine and peanuts [1-3].  
This compound may be of interest to the food industry because it has been extensively shown 
through both in-vitro and in-vivo studies to provide health benefits [4-10].  It has been 
associated with reduction in blood glucose and improvement in plasma glucose in diabetic rats, 
that indicates positive improvements related to diabetes [6].  Resveratrol has also been 
demonstrated to prevent and slow down tumor growth, related to positive effects on cancer [11-
13].  In humans, it has been shown to inhibit platelet aggregation and increase cerebral blood 
flow which decreases the risk of cardiovascular disease [8, 9, 14]. 
 Due to the numerous health benefits associated with resveratrol, it would be valuable for 
the food industry to incorporate the compound into easy-to-consume foods in order to deliver 
the health benefits to consumers.  Resveratrol could be incorporated into food products at levels 
which have been shown to be biologically active.  These levels are much higher than the levels 
naturally found in foods with resveratrol [1-3].  One drawback is the instability of resveratrol in 
the presence of light, in which about 90% of the bioactive form of resveratrol was converted to 
the bio-inactive form of resveratrol after 100 min of light exposure at 366 nm [15].  Another 
limitation with the incorporation of resveratrol into food products is the bitterness associated with 
the compound.  Riesling wine fortified with resveratrol at 20 and 200 mg/L were found to be 
significantly more bitter than the control wine without added resveratrol [16].  Research on the 
sensory properties of resveratrol is very limited and further research should be conducted to 
gain a better understanding, especially related to consumer acceptance of food products with 
added resveratrol.    
 Consumer testing can measure the acceptance of products with added resveratrol.  This 
type of testing uses untrained panelists who are familiar with the type of product being tested.  
The product acceptance can be affected by attributes such as appearance, aroma, taste, and 
texture, but it has been found that taste has the greatest influence on acceptance [17].  The 9-
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point hedonic scale is most commonly used in consumer testing to measure degree of liking.  
This type of scale is easy for panelists to use and easy for researchers to implement [18].  In 
addition to overall liking questions using the 9-point hedonic scale, check-all-that-apply (CATA) 
questions can be used in consumer testing to evaluate product attributes.  There is some 
disagreement on whether the use of CATA questions may bias the hedonic scales when used in 
the same testing procedure.  It has been found that CATA questions have less of an effect on 
hedonic scale ratings in comparison to just-about-right and intensity scale ratings [19].  On the 
other hand, it was found that the completion of attribute analysis along with hedonic ratings 
biased overall ratings [20].  Research supported that rotating presentation order of CATA terms 
or using a forced choice CATA format did not have a significant influence on hedonic scale 
ratings [21].  Consumer testing using the 9-point hedonic scale along with CATA questions with 
a rotating presentation order can be used to evaluate food products with added resveratrol.  
Ratings from this testing can evaluate acceptance of products with encapsulated resveratrol in 
comparison to the unencapsulated resveratrol. 
 The results of our prior research supported that resveratrol encapsulated within a 
sodium caseinate matrix had a significantly higher stability (Chapter 3) and higher taste 
detection threshold in comparison to unencapsulated resveratrol (Chapter 5).  This indicated 
that the encapsulation within a sodium caseinate matrix provided stability and masked negative 
sensory attributes of resveratrol.  Therefore, the objective of this research was to show 
application of the resveratrol microcapsules to easy-to-consume food products and evaluate 
consumer acceptance of these products.  The hypothesis was that products with encapsulated 
resveratrol will have a consumer acceptance not significantly different than the sample without 
any added resveratrol or protein.  The second hypothesis was that there will be a higher 
consumer acceptance for products with encapsulated resveratrol in comparison to the product 
with unencapsulated resveratrol.   
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6.3 Materials and Methods 
6.3.1 Materials 
 Resveratrol and the sodium caseinate used were from Dutch State Mines (DSM, 
Parsippany, NJ) and Agropur (La Crosse, WI), respectively.  The oatmeal, almond milk and 
distilled water were all Meijer® brand (Grand Rapids, MI).  Nestlé® chocolate chips (Vevey, 
Canton of Vaud, Switzerland) and Skippy® peanut butter (Austin, MN) were used for the bar 
samples.  Knox® gelatin (Kraft Foods, Chicago, IL), grape flavored Kool-Aid® (Kraft Foods, 
Chicago, IL), and Jello-O® (Kraft Foods, Chicago, IL) were used for the gummy samples.   
6.3.2 Encapsulated Resveratrol Production 
 Our previous research used 4.8% resveratrol (dry basis, w/w) in the microcapsules but 
the concentration of resveratrol was increased for the consumer testing to minimize the amount 
of microcapsules which needed to be added to the food products.  The microcapsules used in 
the consumer testing contained 9.1% resveratrol and 90.9% sodium caseinate (dry basis, w/w).  
An 8% sodium caseinate solution was mixed, then partially denatured at 80°C for 2 hours in a 
shaking water bath (C76 Water Bath Shaker, New Brunswick Scientific, Edison, NJ).  The 
resveratrol was mixed into the sodium caseinate solution before high-pressure homogenization 
(APV Gaulin Inc., Wilmington, MA) at 55 psi, for two passes.  The resulting solution was spray 
dried in a lab bench spray drier (Buchi B-290, New Castle, DE).  The inlet and outlet 
temperatures for spray drying were 160°C and 90°C, respectively.  The nozzle diameter was 0.7 
mm and flow rate was 4.5-7.5 g/min, in order to maintain a constant outlet temperature. 
6.3.3 Preparing Samples 
 Bar and gummy samples were prepared according to the formulations in Table 6.1.  The 
serving size for bars and gummies were 31 g and 25 g, respectively.  These serving sizes were 
averages of bars and gummies currently on the market.   
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6.3.4 Bars 
 For the bars, all ingredients except oatmeal were microwaved for 2 min on high, then 
mixed by hand for 15 sec.  The heating and mixing was repeated a second time before an 
additional 1 min of heating.  The resveratrol microcapsules, protein, and resveratrol were mixed 
into the heated mixture until thoroughly dispersed.  Then, the oatmeal was added.  Fifteen 
grams of the sample was weighed out and hand-shaped into circular bars.  The samples were 
put into the refrigerator for 30 min in order to set.  Then, the bars were transferred to plastic 
containers and placed in the refrigerator until the day before testing when samples were 
transferred to 60 mL plastic cups with lids.  
6.3.5 Gummies 
 All ingredients were combined and mixed together with a spatula.  Then, the mixture was 
microwaved for 2 min and 45 sec.  The mixture was vortexed to evenly disperse the resveratrol 
microcapsules, protein, and resveratrol in the mixture.  The resulting solution was placed in a 
45°C water bath for 30 minutes under vacuum in order to minimize air incorporated in the 
solution.  Gummies were molded in 1 cm x 1 cm x 1 cm cubes and placed in the freezer to 
harden for 30 min.  Samples were stored in the refrigerator for about 5-7 days in plastic 
containers until the day before testing when samples were transferred to 30 mL plastic cups 
with lids. 
6.3.6 Resveratrol Dosage 
 For both bars and gummies, 10 and 40 mg resveratrol/serving were tested as these are 
effective levels that align with the therapeutic dosages.  Prior research has found 10 mg and 40 
mg of resveratrol to be biologically effective in humans [10, 22, 23].  Resveratrol has been 
shown to be effective in reducing insulin resistance and urinary ortho-tyrosine excretion related 
to positive effects on diabetes at 10 mg/day and having an anti-oxidant and anti-inflammatory 
effect related to anti-aging at 40 mg/day.   
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6.3.7 Panelists 
 There were a total of 100 panelists ranging from 18 to over 65 years of age.  There were 
35 males and 63 females reported.  Two panelists did not answer the question regarding 
gender.  Panelists’ demographics are shown in Figure 6.1. 
6.3.8 Consumer Testing 
The testing took place in the Bevier Hall Spice Box, a large room where meals are 
commonly served in the food science building.  There were two days of testing in which 
gummies were tested on the first day and bars were tested on the second day.  Four different 
controls were used for both gummies and bars: 1) without any resveratrol or protein (Plain), 2) 
unencapsulated resveratrol (Resv), 3) sodium caseinate and unencapsulated resveratrol just 
mixed without encapsulation (P+R), and 4) sodium caseinate only (PRO).  The unencapsulated 
resveratrol and sodium caseinate were added in the same concentration as the resveratrol 
microcapsules which had a resveratrol concentration of 10 and 40 mg.  Therefore, there were a 
total of 9 samples for each of the testing days.  Amounts of protein, resveratrol and 
microcapsules added to each sample are shown in Table 6.2.  
All samples were served to the panelists at once, in a multiple presentation format.  
Samples were served at room temperature and covered with foil until being served to panelists.   
Sample order was randomized among panelists using 25 different sample orders determined by 
the RAND function in Microsoft Excel (Microsoft, Redmond, WA).  All responses were collected 
on paper ballots and a copy of the ballot can be found in Appendix C.  Panelists were asked to 
rate overall liking of each of the samples along with check-all-that-apply (CATA) questions 
regarding what attributes they LIKE and DISLIKE about the samples.  The attributes included in 
the CATA questions were developed through preliminary testing with 7 panelists who were 
experienced in generating descriptive attributes, specifically for these products.  The order that 
the CATA options were presented were randomized using 25 different orders.  
119 
 
6.3.9 Post-Questionnaire 
 Panelists were asked two questions related to health benefits and label claims related to 
resveratrol: “Which of the following health benefits do you associate with resveratrol? (Check all 
that apply)” and “If a product was labeled with “May decrease cancer risk, increase heart health 
and neurological function”, would this increase the chance that you purchase this product over 
another product without a health claim?”  These questions were intended to gauge the panelists’ 
knowledge of resveratrol and purchase intent.    Appendix D shows a copy of the post-
questionnaire. 
6.3.10 Data Analyses 
 All responses were entered from the paper ballots into Microsoft Excel (Microsoft, 
Redmond, WA).  Statistical Analysis Software (SAS, version 9.3, SAS Inst. Inc., Cary, NC) was 
used to analyze overall liking and CATA data.  Analysis of variance (ANOVA) found if there was 
a significant difference across average overall liking of samples and Fisher’s least significant 
difference (LSD) test identified where the difference existed across average overall liking scores 
of samples.  The data generated from the overall liking scores was assumed to be continuous 
data thereby allowing the use of ANOVA and LSD to analyze the data.   
Cochran’s Q Equation, shown below, was used to calculate the significance level of 
each attribute for the CATA data, separately for LIKE and DISLIKE, of each product.   
Cochran’s Equation: Q= 
𝒏𝒌 (𝒏𝒌−𝟏) ∑ (𝑻𝒌−𝑻)^𝟐𝒏𝑲𝒌=𝟏
𝒏𝒌 ∑ 𝑹𝒋
𝒏𝒋
𝒋=𝟏 −∑ 𝑹𝒋^𝟐
𝒏𝒋
𝒋=𝟏
    (eq 6.1) 
nk: number of products 
Tk: number of times attribute was chosen for specific product 
T: total number of times attribute was chosen across all products  
nj: number of panelists 
Rj: number of times attribute was chosen across all products by a specific panelist 
 
Cochran’s Q-value was converted into the p-value using the Chi-squared distribution 
function in Microsoft Excel.  The nonparametric LSD was utilized to find where the difference 
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existed across samples in terms of the number of times an attribute was chosen for LIKE and 
DISLIKE, separately.  XLSAT 2014.4.09 (Addinsoft, New York, NY) was used for agglomerative 
cluster analysis and correspondence analysis.  Agglomerative cluster analysis grouped 
panelists according to their overall liking scores of products with added resveratrol 
microcapsules for gummies and bars, separately.  Correspondence analysis provided a visual 
depiction of the relationship of attributes to each other according to determined groups of 
factors.  
6.4 Results and Discussion 
6.4.1 Overall Liking 
 The average overall liking scores for all samples are shown in Figure 6.2.  There was no 
significant difference in overall liking for bars when comparing samples with equivalent protein 
and/or resveratrol content to SC 10.  In addition, there was no significant difference in overall 
liking between SC 10 bar and the Plain bar.  These results indicated that the addition of 10 mg 
of encapsulated resveratrol to bar samples did not significantly change the overall liking of the 
product.  For the gummies, samples with both concentrations of microcapsules had a 
significantly lower overall liking in comparison to other samples with the equivalent 
concentration of protein and/or resveratrol.  This suggested that the complexity of the food 
matrix affected overall liking scores across samples with encapsulated resveratrol and 
unencapsulated resveratrol.  Bars are complex food matrices and there was no significant 
difference across SC and other samples, while there was a significant difference across SC and 
other samples in gummies. 
Panelists were clustered according to their ratings of samples with resveratrol 
microcapsules (Figure 6.3 and Table 6.3).   Therefore, there was similarity in overall liking 
ratings of panelists within each cluster.  The overall liking scores of the cluster of panelists who 
rated SC samples highest in comparison to the other clusters of panelists (N=23 for bars) show 
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that, for bars, SC 10 had a significantly higher overall liking score than P+R 10 and PRO 10 
(Figure 6.4 and Table 6.4).  The panelists in this cluster liked SC 10 significantly more than 
samples with the same protein content.  For gummies, the overall liking scores of the cluster of 
panelists who rated SC samples highest in comparison to the other clusters of panelists (N=28 
for gummies) were not significantly different than other samples with the same resveratrol 
and/or protein concentrations, for both concentrations of resveratrol microcapsule.  Therefore, 
the resveratrol microcapsules in gummies had no significant effect on overall liking in 
comparison to other samples with the same protein and/or resveratrol concentration.  Also, the 
overall liking scores from this cluster of panelists for SC 10 and SC 40 bar and gummy samples 
were not significantly different from the Plain samples.  Thereby, this finding indicated that the 
addition of encapsulated resveratrol maintained the overall liking of the sample.  
6.4.2 Check-all-that-apply 
The attributes that showed a significant difference (α=0.05) across the number of times 
the attribute was chosen across products are shown in bold in Table 6.5.  For bars, bitter and 
sweet were significant attributes for both LIKE and DISLIKE.  Sweetness has been shown to be 
most resistant to being masked by other tastes [24].  Therefore, the significant differences seen 
in both LIKE and DISLIKE are in line with the literature showing that sweetness is not masked 
by changes in bitterness or sourness.  Chalky and mouth coating were significant attributes for 
both LIKE and DISLIKE in the gummies.  This demonstrates that attributes related to taste 
differentiated bar samples and attributes related to texture differentiated gummy samples.  
Therefore, an increased complexity of the sample matrix may help to mask textural impacts of 
added resveratrol microcapsules. 
The results of the nonparametric LSD performed on the CATA data are shown in Table 
6.6.  The number of times bitter was chosen as a DISLIKE attribute for bars with added 
resveratrol microcapsules was significantly higher than all other products with equivalent protein 
and/or resveratrol concentrations.  When comparing the non-parametric LSD for gummies, Resv 
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40 was selected significantly more times for chewy, mouth coating and smooth as a LIKE 
attribute than SC 40.  There was no significant difference across the number of times SC 40 
was chosen as a LIKE attribute in comparison to PRO 40 and P+R 40 for chewy, mouth coating 
and smooth.  Therefore, the protein content in the sample was most likely attributed to the 
difference in chewy, mouth coating and smooth for LIKE attributes of gummies.  Sweet was 
selected as a DISLIKE attribute the most for Plain, which was significantly higher than all 
products with unencapsulated resveratrol and encapsulated resveratrol.  These results are not 
in agreement with prior research as it has been found that bitterness and sweetness were 
negatively correlated so increased levels of bitterness resulted in decreased ratings of 
sweetness [25].  Therefore, it would be expected that samples with resveratrol would have 
sweet chosen as a DISLIKE option significantly more than samples without resveratrol.  This 
may be an indication that the Plain sample was the least sweet and consumers did not like it 
because the sweetness was not on par with the other samples.  The CATA questions indicate 
differences between the number of times a specific attribute was chosen for LIKE and DISLIKE.  
These questions do not indicate intensity of the attributes but descriptive analysis could be used 
to accomplish this.  
Complexity of the samples may be attributed to differences seen across the CATA 
results of bars and gummies since the matrix of bars was more complex than that of gummies.  
Discrimination testing between caffeinated and uncaffeinated solutions showed that ability to 
discriminate between samples was affected by complexity of the beverage such as flavor, 
sweetness and carbonation [26].  It has also been found that increasing the complexity of odor-
taste mixtures decreased that ability of trained panelists to identify specific components [27, 28].       
  According to correspondence analysis for the LIKE attributes of bars, the attributes that 
were closely related to each other but separated from the other attributes were 1) bitter and 
sour, 2) chalky and hard, and 3) astringent (Figure 6.5).  For the LIKE attributes of gummies, the 
attributes that were separated from the others but also not associated with each other were 1) 
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hard, astringent, foamy, bitter and 2) chalky.  The attributes that were separated from the 
internal cluster of attributes are the drivers of liking and disliking between the products.  Future 
research could utilize descriptive analysis to evaluate the intensity of specific attributes of the 
bar and gummy samples, in order to confirm the findings from the correspondence analysis.     
The overall findings of this study suggested that the complexity of the food matrix can affect 
whether a difference exists across the overall liking of products with added resveratrol 
microcapsules and the controls.   Also, there may be a segment of consumers who prefer 
products with encapsulated resveratrol in comparison to products with the same concentration 
of protein and/or unencapsulated resveratrol.  For this segment of consumers, it was also found 
that overall liking of both bars and gummies with encapsulated resveratrol was maintained in 
comparison to the Plain sample.  The CATA data indicated that taste differentiated the bar 
samples while texture distinguished gummy samples.   
6.4.3 Post-Questionnaire 
The post-questionnaire asked the panelists about prior knowledge of the health benefits 
related to resveratrol and the effect of a health claim related to resveratrol on purchase intent.  
For the questions related to prior knowledge of resveratrol, the option “I don’t know what 
resveratrol is” was chosen that most, followed by “Prevent/treat cardiovascular disease” and 
“anti-aging” (Figure 6.6).  Also, most panelists indicated that the health claim related to 
resveratrol would increase their purchase intent of the product.  The results of the health claim 
related to resveratrol showed that the claim would increase the chance that consumers would 
purchase the product (Figure 6.7).  Therefore, in order to positively influence the purchase intent 
of consumers, it would be better to include health claims related to resveratrol rather than just 
stating the resveratrol content since most panelists did not know of resveratrol. 
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6.5 Conclusion 
This research provides a basis upon which the food industry can add stabilized 
resveratrol into food products in order to deliver the health benefits to the consumer.   The 
benefit of using resveratrol microcapsules is that the encapsulation matrix helps to protect the 
compound and maintain its bioactivity.  The overall liking of SC 10 in bars was not significantly 
different than that of the Plain sample.  In addition, a group of panelist was identified who had a 
higher overall liking for the SC 10 bar sample in comparison to the bar sample with both 
unencapsulated resveratrol and protein (P+R 10) and the bar sample with equivalent amount of 
protein (PRO 10).  Therefore, these types of products with added resveratrol should be targeted 
towards a segment of the market who prefer these products.  Some limitations of this study 
were that only two levels of resveratrol concentration and only two types of food products were 
tested, as consumer acceptance of additional food matrixes may differ from those tested in this 
research.  Future research could evaluate consumer acceptance of other complex food matrices 
utilizing additional resveratrol concentrations that have been shown to have therapeutic effects.  
Another limitation of the study is that for the CATA questions, it is not possible to determine if 
the panelists checked an attribute because it was present or not present.  Therefore, descriptive 
analysis would be helpful to determine attribute intensities of products with added resveratrol.   
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6.6 Figures and Tables 
Figure 6.1: Demographics of panelists who participated in consumer testing of food 
products with added resveratrol: A) Ethnicity, B) Age (years of age) 
 
 
 
There were a total of 100 panelists who participated in the consumer testing. 
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Figure 6.2:  Average overall liking scores of panelists from the consumer testing of  
A) Bars and B) Gummies, with added unencapsulated resveratrol and encapsulated 
resveratrol.   
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Same letters represent not significantly different values (p<0.05, ANOVA and LSD) 
Average overall liking scores indicated above each sample bar 
Plain: no added resveratrol or protein, PRO 10: same sodium caseinate concentration as SC 
10, PRO 40: same sodium caseinate concentration as SC 40, Resv 10: 10 mg of 
unencapsulated resveratrol, Resv 40: 40 mg of unencapsulated resveratrol, P+R 10:  same 
sodium caseinate and resveratrol concentration as SC 10, P+R 40:  same sodium caseinate 
and resveratrol concentration as SC 40, SC 10: 110 mg resveratrol microcapsule, SC 40: 439.6 
mg resveratrol microcapsules. 
5.66 5.62
5.16
5.63 5.68 5.43 5.34
4.94
4.31
1
2
3
4
5
6
7
8
9
Plain PRO 10 PRO 40 Resv 10 Resv 40 P+R 10 P+R 40 SC 10 SC 40
a a a 
ab a 
a 
ab 
b c 
B) 
5.82 5.89
6.19 6.07
5.28
5.81
5.38
5.73
4.99
1
2
3
4
5
6
7
8
9
Plain PRO 10 PRO 40 Resv 10 Resv 40 P+R 10 P+R 40 SC 10 SC 40
A) 
ab a a ab cd a bcd abc d 
127 
 
There were a total of 100 panelists who participated in the consumer testing. 
 
Figure 6.3: Cluster analysis of panelists based on overall liking ratings of samples with 
encapsulated resveratrol for: A) Bars and B) Gummies.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The concentration of encapsulated resveratrol within the food products was 10 and 40 
mg/serving.  The cluster with a box around it represents panelists who rated the samples with 
encapsulated resveratrol higher than the other two clusters of panelists.   
There were a total of 100 panelists who participated in the consumer testing. 
Panelists were clustered using agglomerative cluster analysis. 
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Figure 6.4:  Average overall liking scores for cluster of panelists who rated samples with 
resveratrol microcapsules highest for: A) Bars (N=23) and B) Gummies (N=28) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Same letters represent not significantly different values (p<0.05, ANOVA and LSD) 
Average overall liking scores indicated above each sample bar 
Plain: no added resveratrol or protein, PRO 10: same sodium caseinate concentration as SC 
10, PRO 40: same sodium caseinate concentration as SC 40, Resv 10: 10 mg of 
unencapsulated resveratrol, Resv 40: 40 mg of unencapsulated resveratrol, P+R 10:  same 
sodium caseinate and resveratrol concentration as SC 10, P+R 40:  same sodium caseinate 
and resveratrol concentration as SC 40, SC 10: 110 mg resveratrol microcapsule, SC 40: 439.6 
mg resveratrol microcapsules 
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Figure 6.5: Correspondence analysis from check-all-that-apply questions on attributes 
that are liked and disliked for A) Bars LIKE, B) Bars LIKE (zoomed in on central cluster) 
C) Bars LIKE for only significant attributes according to Cochran’s Q equation, D) Bars 
DISLIKE, E) Bars DISLIKE for only significant attributes according to Cochran’s Q 
equation F) Gummies LIKE, G) Gummies LIKE for only significant attributes according to 
Cochran’s Q equation, H) Gummies DISLIKE, I) Gummies DISLIKE for only significant 
attributes according to Cochran’s Q equation 
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Figure 6.6: Prior knowledge of resveratrol health benefits of panelists who participated in 
consumer testing of products with added resveratrol 
 
 
There were a total of 100 panelists who participated in the consumer testing. 
 
Figure 6.7: Effect of health claim related to resveratrol on purchase intent of product for 
panelists who participated in consumer testing of products with added resveratrol 
 
 
There were a total of 100 panelists who participated in the consumer testing. 
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Table 6.1:  Formulation of bar and gummy samples used in consumer testing of products 
with added resveratrol   
 
Bar (per serving) 
8 g oatmeal (Meijer®, Grand Rapids, MI) 
6 g milk chocolate chips (Nestlé®, Vevey, Canton of Vaud, Switzerland) 
11 g peanut butter (Skippy®, Austin, MN) 
6 g almond milk (Meijer®, Grand Rapids, MI) 
 
Gummy (per serving) 
2.95 g gelatin (Knox®, Kraft Foods, Chicago, IL) 
2.25 g kool-aid (Kool-Aid®, Kraft Foods, Chicago, IL) 
3.9 g jello (Jell-O®, Kraft Foods, Chicago, IL) 
15.9 g distilled water (Meijer®, Grand Rapids, MI) 
 
Serving size of bars are 31 g and serving size of gummies are 25 g. 
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Table 6.2: Sample codes and amount of unencapsulated resveratrol, sodium caseinate, 
and encapsulated resveratrol added to each serving in consumer testing of food 
products with added resveratrol 
 
Sample Code 
Unencapsulated 
resveratrol 
Sodium Caseinate 
Encapsulated 
Resveratrol  
Plain -- -- -- 
PRO 10 -- 100 mg -- 
PRO 40 -- 399.6 mg -- 
Resv 10 10 mg -- -- 
Resv 40 40 mg -- -- 
P+R 10 10 mg 100 mg -- 
P+R 40 40 mg 399.6 mg -- 
SC 10 -- -- 110 mg 
SC 40 -- -- 439.6 mg 
 
Plain: no added resveratrol or protein, PRO 10: same sodium caseinate concentration as SC 
10, PRO 40: same sodium caseinate concentration as SC 40, Resv 10: 10 mg of 
unencapsulated resveratrol, Resv 40: 40 mg of unencapsulated resveratrol, P+R 10:  same 
sodium caseinate and resveratrol concentration as SC 10, P+R 40:  same sodium caseinate 
and resveratrol concentration as SC 40, SC 10: 110 mg resveratrol microcapsule, SC 40: 439.6 
mg resveratrol microcapsules. 
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Table 6.3: Number of panelists in each cluster (N), average overall liking scores of SC 10 
and SC 40 according to cluster analysis of overall liking scores of products with 
resveratrol microcapsules 
 
 Bars Gummies 
Cluster 1 
N = 23 
SC 10 average = 7.0 
SC 40 average = 7.5 
N = 28 
SC 10 average = 6.9 
SC 40 average = 6.1 
Cluster 2 
N = 57 
SC 10 average = 4.8 
SC 40 average = 5.6 
N = 28 
SC 10 average = 4.7 
SC 40 average = 2.1 
Cluster 3 
N = 13 
SC 10 average = 2.3 
SC 40 average = 3.2 
N = 39 
SC 10 average = 3.6 
SC 40 average = 4.6 
 
Panelists were clustered according to their overall liking scores of SC 10 and SC 40, separately 
for bars and gummies. 
SC 10: 110 mg resveratrol microcapsule, SC 40: 439.6 mg resveratrol microcapsules. 
There were a total of 100 panelists who participated in the consumer testing. 
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Table 6.4: Overall liking of samples for each cluster of panelists for A) Bars and B) 
Gummies  
A) 
Sample Code Cluster 1 Cluster 2 Cluster 3 
Plain 7.05abc 5.64a 4.85a 
PRO 10 6.57bc 5.98a 4.69ab 
PRO 40 7.30ab 5.88a 5.54a 
Resv 10 6.90abc 5.93a 4.82ab 
Resv 40 6.23c 5.43ab 2.92cd 
P+R 10 6.45c 5.71a 5.00a 
P+R 40 6.96abc 5.05bc 3.58bc 
SC 10 7.48a 5.61a 3.15cd 
SC 40 7.00abc 4.77c 2.31d 
 
B)  
 
Sample Code Cluster 1 Cluster 2 Cluster 3 
Plain 6.67ab 5.11ab 5.37ab 
PRO 10 6.54ab 5.19ab 5.41a 
PRO 40 6.24ab 4.96ab 4.68bc 
Resv 10 6.54ab 5.60a 5.05abc 
Resv 40 6.52ab 5.68a 5.03abc 
P+R 10 6.64ab 4.93ab 5.00abc 
P+R 40 6.07b 5.44ab 4.78abc 
SC 10 6.93a 4.71b 3.64d 
SC 40 6.07b 2.07c 4.64c 
 
Panelists were clustered according to their ratings of SC 10 and SC 40 using agglomerative 
cluster analysis. 
Same letters represent not significantly different values (p<0.05, ANOVA and LSD). 
Plain: no added resveratrol or protein, PRO 10: same sodium caseinate concentration as SC 
10, PRO 40: same sodium caseinate concentration as SC 40, Resv 10: 10 mg of 
unencapsulated resveratrol, Resv 40: 40 mg of unencapsulated resveratrol, P+R 10:  same 
sodium caseinate and resveratrol concentration as SC 10, P+R 40:  same sodium caseinate 
and resveratrol concentration as SC 40, SC 10: 110 mg resveratrol microcapsule, SC 40: 439.6 
mg resveratrol microcapsules. 
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Table 6.5: P values for each attribute from Cochran’s Q equation which determines if a 
significant difference exists across the number of times an attribute was chosen in the 
check-all-that-apply questions on ballot of LIKE and DISLIKE across products as 
evaluated in consumer testing of A) bars and B) gummies with added resveratrol 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GUMMY LIKE DISLIKE 
Astringent 0.310 0.703 
Bitter 0.473 0.125 
Chalky *0.018 *<0.001 
Chewy *0.047 0.269 
Foamy 0.126 *0.003 
Fruity 0.104 0.699 
Hard 0.074 *0.019 
Mouth Coating *0.004 *0.004 
Rubbery 0.394 0.099 
Salty 0.721 0.084 
Smooth *0.001 0.389 
Soft 0.604 0.555 
Sour 0.381 0.286 
Sticky 0.528 0.064 
Sweet 0.190 *0.002 
      *Significant values (α=0.05) are shown in bold 
BAR LIKE DISLIKE 
Astringent 0.433 *0.003 
Bitter *0.042 *<0.001 
Chalky 0.055 0.154 
Chewy 0.395 0.336 
Chocolate Flavor 0.285 0.232 
Cohesive 0.362 0.510 
Fatty 0.903 *0.006 
Hard 0.226 0.633 
Moist 0.120 0.066 
Mouth Coating *0.027 0.412 
Oaty 0.255 0.065 
Peanut butter Flavor *0.005 0.742 
Salty 0.553 0.633 
Soft 0.389 0.452 
Sour 0.473 *0.029 
Sticky 0.201 0.076 
Sweet *0.004 *0.034 
Tooth Packing 0.881 0.825 
A) 
B) 
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Table 6.6: Nonparametric LSD results for check-all-that-apply questions showing 
differences across the number of times attributes were chosen across samples for A) 
Bars and B) Gummies, as evaluated by consumer testing on food products with added 
resveratrol  
 
A) 
 LIKE DISLIKE 
Sample Bitter Mouth 
Coating 
Peanut 
Butter 
Flavor 
Sweet Astringent Bitter Fatty Sour Sweet 
Plain 1B 19A 64ABC 54AB 4BCD 13CD 15ABC 0B 8A 
PRO 10 2AB 6B 66ABC 47AB 0D 8D 14ABC 2AB 8A  
PRO 40 0B 13AB 59C 58A 5BCD 8D 6C 1B 1B 
Resv 10 0B 12AB 75A 57A 3BCD 10D 13ABC 2AB 4AB 
Resv 40 5A 10B 62ABC 43B 8AB 31B 21A 2AB 5AB 
P+R 10 1B 10B 67ABC 53AB 2CD 11D 14ABC 3AB 8A 
P+R 40 1B 9B 56C 42B 6ABC 31B 11BC 6A  5AB 
SC 10 0B 11AB 73AB 51AB 4BCD 22BC 19AB  1B 4AB 
SC 40 2AB 8B 60BC 41B 11A 49A 11BC 6A  2AB 
 
 
B) 
 LIKE DISLIKE 
Sample Chalky Chewy 
Mouth 
Coating Smooth Chalky Foamy  Hard 
Mouth 
Coating Sweet 
Plain 1B 41AB 6ABC 31ABC 6B 11AB 11BC 3C 13A 
PRO 10 1B 39AB 11AB  30ABC 4B 8B 14ABC 7BC 9AB 
PRO 40 4A 30B 4BC 24BCD 26A 12AB 15ABC 12AB 7ABC 
Resv 10 1B 37AB 8ABC 33AB 11B 8B 16ABC 10ABC 3BC 
Resv 40 1B 45A 13A 37A 7B 8B 7C 7BC 6BC 
P+R 10 1B 37AB 6ABC 30ABC 9B 8B 16ABC 18A  3BC 
P+R 40 1B 38AB 9ABC 19CD 26A 18A 11BC 9BC 5BC 
SC 10 1B 44A  4BC 26ABCD 23A 9B 19AB 13AB 6BC 
SC 40 3A 30B 2C 17D 32A 19A 23A  13AB 2C 
 
Same letters represent not significantly different values (p<0.05, ANOVA and LSD) 
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CHAPTER 7: SUMMARY 
  
Bioactive compounds, such as resveratrol, can help to prevent and alleviate certain 
disease states.  The incorporation of these compounds in food products can provide convenient 
means to deliver the health benefits to consumers.  Microencapsulation is an innovative 
processing method that can help to stabilize the compounds during processing, storage, and 
digestion, and minimize negative sensory properties of the compounds. 
 Whey protein and sodium caseinate were compared as encapsulation materials 
evaluated by UVA light testing and a 3-stage in-vitro digestion model.  After exposure to UVA 
light, the trans:cis resveratrol ratios of samples were compared and a higher trans:cis 
resveratrol ratio indicated higher UVA light stability.  Sodium caseinate as a wall material for 
encapsulation enhanced UVA light stability of resveratrol (0.63 trans:cis resveratrol ratio) in 
comparison to whey protein concentrate (0.43 trans:cis resveratrol ratio) and unencapsulated 
resveratrol (0.49 trans:cis resveratrol ratio).  In addition, stability through the human digestive 
system evaluated by digestive stability and bioaccessibility of sodium-caseinate-based 
microcapsules, whey-protein-concentrate-based microcapsules and unencapsulated resveratrol 
were 84% and 60%, 70% and 53%, and 47% and 23%, respectively.  The addition of anhydrous 
milk fat in the formulation did not have a significant effect on the stability of resveratrol within the 
microcapsule.  The addition of plasticizers to the microcapsule formulations caused a decrease 
in UV stability of resveratrol (0.39 trans:cis resveratrol ratio) compared to the original 
microcapsule formulation (0.64 trans:cis resveratrol ratio).  The encapsulation of resveratrol also 
helped to decrease the detection of resveratrol.  The taste threshold of encapsulated resveratrol 
(313-334 mg resveratrol/L) was significantly higher than that of the unencapsulated resveratrol 
(90 mg resveratrol/L).  In terms of consumer acceptance of products with added resveratrol, a 
segment of consumers was identified whose overall liking scores of both bars and gummies with 
encapsulated resveratrol were not significantly different from the plain samples (without any 
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resveratrol).  Therefore, overall liking of the products was maintained when encapsulated 
resveratrol was added to the products.    
 Stabilization of resveratrol was achieved through microencapsulation within a protein 
matrix using spray drying.  In the food industry, spray drying is a common technique and the 
equipment is readily available to make the scale up and production of resveratrol microcapsules 
feasible.  In addition, the relatively low cost of protein helps to minimize the cost of the 
encapsulation, thereby minimizing the additional cost of providing a stabilized form of resveratrol 
to the consumer.   
 The developed encapsulation system is valuable as it can serve as a model into which 
other components can be incorporated, such as bioactive polyphenols such as quercetin, 
micronutrients such as iron, probiotics and flavor compounds for protection and controlled 
release.  Future research can also compare the ability of other types of proteins, such as soy 
protein and pea protein, to stabilize resveratrol utilizing encapsulation.   These proteins are 
more suitable for individuals who are vegan or have dietary sensitivities to dairy foods.  Future 
research could also evaluate taste detection thresholds of resveratrol within food products as 
these levels may be different than those in aqueous solutions.  It would also be interesting to 
add the resveratrol microcapsules to other complex food products, chocolate and protein 
shakes, and evaluate consumer acceptance of these products.  Consumer testing could also be 
completed on food products with added resveratrol, with and without the information regarding 
health benefits of resveratrol.  In this way, the effect of the information about resveratrol on 
consumer acceptance of the product could be determined.  In addition, further research can 
utilize descriptive analysis to evaluate product attribute intensities in order to confirm CATA 
question results regarding attributes related to LIKE and DISLIKE attributes.   
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CHAPTER 8: APPENDICES 
Appendix A: Apparent solubility of 180 mg Resveratrol/L in 1.2% Ethanol Solution 
 
Resveratrol Concentration (µg/mL) 
Amount Detected in Sample 181  
Standard Deviation 9.3 
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Appendix B: Post-Questionnaire for Threshold Testing of Resveratrol 
DEMOGRAPHICS QUESTIONNAIRE 
 
We want to ask you a few questions about yourself.  This information will help us compare opinions 
of people with different backgrounds.  All information is confidential and will not be identified with 
your name.  You may choose not to answer questions, if you wish, as your participation is voluntary. 
 
1. How old are you? 
 
 18-25 years old 
 
 26-35 years old 
 
 36-45 years old 
 
 46-55 years old 
 
 56-65 years old 
 
  Over 65 years old 
 
 
2. What is your gender? 
 
  Male 
 
  Female 
 
 
3. How do you describe yourself? (check all that apply) 
 
  American Indian or Alaska Native 
  
  Asian 
 
  Black or African American 
 
  Caucasian 
 
  Hispanic or Latino 
 
  Native Hawaiian or Other Pacific Islander 
 
  Other:                                        
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Appendix B (cont.) 
4. When purchasing a food product which of the following criteria are most important to you? 
(Rank from 1 = most important to 5 = least important, no ties) 
____ Convenience  
 
____ Health benefits 
 
____ Nutrient content 
 
____ Price 
 
____ Taste 
         
5. What product would be best aligned with the health claim “May decrease cancer risk, increase 
heart health and neurological function”?  (Rank from 1 = most important to 4 = least 
important, no ties) 
____ Snack Bar 
 
____ Yogurt 
 
____ Cookie 
 
____ Drink 
 
 
6. Which of the following health benefits do you associate with resveratrol? (Check all that 
apply) 
  Anti-aging  
 
  Improved Neurological Function 
 
  Lower blood sugar levels 
 
  Prevent/treat cancer 
 
  Prevent/treat high blood pressure/hypertension 
 
  Prevent/treat cardiovascular diseases 
 
  Skin health 
 
  I am not aware of any of the health benefits associated with resveratrol 
 
  I do not know what resveratrol is 
 
  Other:                                
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Appendix C: Ballot for Consumer Testing on Food Products with Resveratrol 
OVERALL ACCEPTANCE OF NUTRACEUTICAL BARS 
Instructions:  
1. Before each sample please rinse in the following manner: 
a. Rinse your mouth with warm water. 
b. Rinse your mouth with carbonated water. 
c. Rinse your mouth with room temperature water. 
2. Check to ensure that the 3-digit code on the sample cup matches the one written in 
above the question. 
3. Repeat the rinse procedure between each sample and evaluate the samples in the 
order they are presented on this page.  
Sample Number: 506    
How much do you like this sample overall?   
         
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
   Neither 
like nor 
dislike 
   Like 
extremely 
What attributes of the product do you LIKE? (check all that apply) 
 Peanut butter flavor 
 Bitter 
 Sour 
 Astringent 
 Soft 
 Salty 
 Hard 
 Tooth packing 
 Cohesive 
 Sticky 
 Moist 
 Mouth coating 
 Chewy 
 Fatty 
 Oaty 
 Chocolate flavor 
 Chalky 
 Sweet 
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Appendix C (cont.) 
What attributes of the product do you DISLIKE? (check all that apply) 
 Peanut butter flavor 
 Bitter 
 Sour 
 Astringent 
 Soft 
 Salty 
 Hard 
 Tooth packing 
 Cohesive 
 Sticky 
 Moist 
 Mouth coating 
 Chewy 
 Fatty 
 Oaty 
 Chocolate flavor 
 Chalky 
 Sweet 
 
 
Other Comments: 
 
 
 
 
 
 
PLEASE RINSE NOW:  First with warm water, then with carbonated water, and then with 
room temperature water. 
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Appendix D: Post-Questionnaire for Consumer Testing on Food Products with 
Resveratrol 
DEMOGRAPHICS QUESTIONNAIRE 
 
We want to ask you a few questions about yourself.  This information will help us compare opinions 
of people with different backgrounds.  All information is confidential and will not be identified with 
your name.  You may choose not to answer questions, if you wish, as your participation is 
voluntary. 
 
1. How old are you? 
 
 18-25 years old 
 
 26-35 years old 
 
 36-45 years old 
 
 46-55 years old 
 
 56-65 years old 
 
  Over 65 years old 
 
 
2. What is your gender? 
 
  Male 
 
  Female 
 
 
3. How do you describe yourself? (check all that apply) 
 
  American Indian or Alaska Native 
  
  Asian 
 
  Black or African American 
 
  Caucasian 
 
  Hispanic or Latino 
 
  Native Hawaiian or Other Pacific Islander 
 
  Other:                                        
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Appendix D (cont.) 
4. Which of the following health benefits do you associate with resveratrol? (Check all that 
apply) 
 
  Anti-aging  
 
  Improved Neurological Function 
 
  Lower blood sugar levels 
 
  Prevent/treat cancer 
 
  Prevent/treat high blood pressure/hypertension 
 
  Prevent/treat cardiovascular diseases 
 
  Skin health 
 
  I am not aware of any of the health benefits associated with resveratrol 
 
  I do not know what resveratrol is 
 
  Other:                                
 
 
5. If a product was labeled with “May decrease cancer risk, increase heart health and 
neurological function”, would this increase the chance that you purchase this product over 
another product without a health claim? 
 
  Very Likely  
 
  Likely 
 
  Somewhat Likely 
 
  No Effect 
 
  Somewhat Unlikely 
 
  Unlikely 
 
  Very unlikely 
 
You have now completed the test. Thank you for your participation.  
Please return your ballot.   
 
